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PRECLINICAL STUDY OF PAVALAVEERA CHUNNAM 1
1. INTRODUCTION
Nature cures, not the physician
- Hippocratus
Natural Health is green health.
Siddhars were men of highly lectured intellectual and spiritual faculties combined
with super natural powers. This system has been developed purely by the contribution of
siddhars on their own line of  thinking and achievements in the field & their research.
This system of medicine was found by siddhars on the basic principles of nature and its
elements, six taste, six seasons, three Thodam (vada, pitha, kabham) after careful and
through study of human systems. This basic dictum in the science of life propounded by
the great siddhar, Thirumoolar, three thousand years ago is as follows.
         “Medicine means one that ensures physiotherapy
Medicine means one that ensures psychotherapy
Medicine means one that ensures prevention of disease
Medicine means one that ensures prevention against mortality
(Thirumoolar 3000)
The functioning of human body is governed by 96 specific faculties (or) thathuvams.
The word siddha comes from the word “Siddhi” which means an object to be
attained or perfection or heavenly bliss. Siddhi refers to Astama Siddhi. These siddhars
who attained or achieved the above said powers in life are known as. Accordingly “Man
has five sense organs to perceive objects Thirukkural says,”
“²¬õ åO áÁæ¬ê ï£Ÿøâ¡ø ä‰F¡
õ¬èªîKõ£œ è†«ì àô°”
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In siddha system every drug is made up of five boothams and has got the following
properties. They are suvai (Taste) Gunam (paroperty) Veeriyam (potency) Privu (Bio formto)
Mahimai (effect)
Arusuvai is contributed by panchaboothams:
Inippu - Appu + Piruthivi
Pulippu - Piruthivi + Theyu
Karppu - Vayu + Theyu
Kaippu - Vayu + Agayam
Thuvarppu - Vayu + Piruthivi
Yuvarppu - Theyu + Appu
Tastes which provide by the bootham are classified as
Veppa veeria suvaigal - pulippu, Karppu and uvarppu.
Seetha Veeria Suvaigal- Inippu, Thuvarppu and Kaippu.
1. Catabolic potency -àwíiKò‹
2. Anabolic potency - YîiKò‹
By knowing the cause of the disease we can change, the change the medicines by
administrating the other type of veeria drug so that the affected thosam can be normalized.
¹O¶õ˜ M…C¡ ÌK‚°‹ õ£î‹
åOàõ˜ ¬èŠ«ðP™ Hˆ¶„YÁ‹
è£˜ŠHQŠ¹ M…CŸ èð‹ M…²‹
This line of treatment is called as ‘Ethirurai’
Sometimes drugs with the same veeriyam are also used to cure the disease and this
sort of treatment is called “Oppurai” and mixed type of treatment is called “Kalappurai.”
Each and everything in the cosmos has its own inherent qualities and according to
these properties it has got one to mole actions and effects called “Gunam or porul panbu”.
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Porul ponbu is a total action of drug. The same drug is administered to different diseases.
But only the Anubanam is changed according to the particular nature of the disease.
Marunthu means which cure physical, Mental illness, which possesses preventive aspect
from disease and also to postpone death.
The art of Practice of curing and treating illness and prevention illness is called
Maruthuvam who practice such a science is called Maruthuvars.
Pathiyam is a medical advice which includes life style modification and dietary
modification as per diseased condition. Pathiyam which is peculiar to Siddha system of
medicine.
Anubanam means it is adjuvant to medicine. It acts as a catalysts and enhances the
rate of absorption of medicine.
They are many categories 25 varieties of water soluble( padanam – Arsenic),
inorganic compounds (Karasaram - salt) 64 varieties, mineral drugs do not dissolve in
water but emit, Vapor when put in fire.
It is a medical science through which the body as well as the soul are treated. It
comprises of four main branches called Vatham,  Maruthuvam, Yogam and Gnanam. The
siddha system has not only the Gratitude and  preventive effects on different diseases but
also paves the way for longevity and immortality.
Siddhars used 5 form of Mercury.
            1. Mercury - Rasam.
            2. Red sulphide of Mercury - Lingam.
            3. Mercury chloride (Terlinguaite) - Veeram.
            4. Mercury subchloride (calomel) - Pooram.
         5. Red oxide of Mercury - Rasa chenduram.
Research is necessary to solve such apparent middles of the transformation of
these admittedly poisonous compounds. These inorganic group of drugs are usually
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appreciated for their smaller dosage, long shelf life and easy palatability, most importantly
for their sustainable quicker results in wide range of degenerative and refractory diseases.
Present day siddha physicians also use many inorganic chunnam preparations in ailing
human conditions like Rheumatoid arthritis,Cancer and HIV.
However there are a few higher order dosage forms like Kattu, Karpam
Kazhangu,Chunnam, and Gurukuligai that are highly acclaimed in literature but seldom
used by modern day physicians.
Siddhars methods of preparation of medicines are more scientific and involutes
high order of chemistry science the global attention now turns towards alternative system
of medicine and appreciated by the scientists and physicians belonging to different system
of medicines. As the greatness of siddha system is now felt by every body.
My selection of the drug “PAVALAVEERACHUNNAM” is taken from “The
Pharmacopoeia of Siddha Research Medicines” Authored by Shanmugavelu.M. In siddha
system of medicine many formulations are available for the management of Liver disease,
Jaundice (Kamalai), Gallstones, Billiarystones, Hepatic stones. Chunnam is a specialized
medicine in siddha system. In current research an attempt is made to investigate,
“PAVALAVEERACHUNNAM” for its Hepatoprotective, Hypolipidemic, Diuretic,
Lithotriptic activities.
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2. AIM AND OBJECTIVES
Aim
Scientific studies reveal that higher order medicines of Siddha like Parpam
,Chenduram, Kattu, Pathangam ,Kalangu and Chunnam contain nano particle. They have
high therapeutic value in treating challenging diseases.The aim of this study is to do a
scientific review to validate the safety and efficacy of ‘PAVALAVEERACHUNNAM’ for
Hepatoprotective by pre-clinical studies.
Objectives
The following methodology was adopted to evaluate the safety and efficacy of the test
drug.
1. To collect the relevant Classical Siddha literature as well as Modern Sciences that
supports the study.
2. To standardize the preparation of the drug according to classical siddha literature.
3. To subject the drug into Physico chemical analysis.
4. To analyze the drug chemically for the detection of acidic and basic radicals.
5. To Estimate the percentage of elements present in the drug by Instrumental analysis.
6. To evaluate the acute and sub-acute toxicity studies profile of Pavalaveerachunnam
according to OECD guidelines.
7. To Establish the following Pharmacological activities:
 Hepatoprotective activity
 Hypolipidemic activity
 Diuretic activity
 Lithotriptic activity
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3. REVIEW OF LITERATURE
3.1. VEERAM (Savveeram) :
3.1.1. GUNAPADAM ASPECT:
Synonyms :
 Meenachimynthan, Kotchiveeram, Poovindhusevagan, Sarakku chunnam, Parangi
Pasanam, Sarathin sathru, Parimithru
ãPò ióªñõ¬ó‚ Ã®«ù£¡
ÝPò MŸð¡ù£F ªõœ¬÷ ªê‰Éó‰
«îPò «êõè¡ «ê˜ Hìó£èù£‹
ÃPò ióƒ ªè£œAò ï£ñ«ñ.
ê†ìºQ Gè‡´
According to the above version the synonyms are Virpan, Aathi, Vellai chenduram,
Sevagan, Pidaragan, Varagathinthalai
Origin:
Veeram is one of the natural in 64 padanams. Naturally it is obtained in Himalaya
hills.
Now we use the artificial one. It is called as Savveeram. It is identified in seventh
century and used for venereal diseases during the middle of the eighteenth century in
western countries. Built for many centuries in siddha system the Veeram has been used in
India for the treatment of various disorders.
Synthetic preparations (Vaippu)
Ingredients:
Calomel - 80 parts
Culinary salt - 80 parts
Copper sulphate - 40 parts
Alum - 20 parts
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Potassium nitrate - 20 parts
Fuller’s earth - 20 parts
Sulphate of iron - 10 parts
Ammonii chloridum - 5 parts
These ingredients are taken and triturated well and placed in a bottle its mouth is closed
and sealed with a mud pasted cloth and burnt. After cooling, the per chloride of mercury is
found to be de­posited over the lid as a thick layer.
Specialities :
 It is a very important drug for preparing Parpam, Chendooram and Guru
 It is having the capacity to make kattu of 64  drugs
 Make karam into kattu medicine form.
Methods of purification and detoxification:
Perchloride of mercury is as such quite toxic and it should be used only after
purification and detoxification.
Perchloride of mercury 35gm is consolidified with pepper de­coction (Piper nigurm)
for 6 hours. Then it is buried within the pep­per poultice. Sodium chloride 650 gm and
camphor 35 gm are mixed well and kept in a mud pot in which the above poultice is buried
and burnt for some hours with low intensity fire to get the purified form of perchloride of
mercury.
Method I:
Camphor is mixed with tender coconut water and placed in a mud pot. Perchloride of
mercury is tied in a cloth and soaked in the pot without touching the water and the pot is
burnt for half an hour.
Method II:
Alum 35 gm and Camphor-35 gm. are powdered well and mixed together.
Perchloride of mercury 35 gm is taken single piece and consolidified by the above mixture
gradually. Perchloride of mer­cury is carefully watched not to become fume.
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Method III :
Perchloride of mercury is soaked in mother’s milk in a porce­lain vessel. It is
isolated till the milk is completely dried to get the purified form. Cow’s milk can be also
used instead of mother’s milk.
Method IV :
Bitter gourd (Momordica charantia ) is opened and a hole is made, perchloride of
mercury is placed in the center of the hole and closed, tied with a rope. Tender coconut
water (or) lime juice is poured in a mud pot. The above tied material is suspended in the
pot without touching the water and burnt for one hour.
Method V
 Veeram is covered by pepper paste and tied in the cloth. Tender coconut water
placed in the mud pot. The above material soaked in the pot without touching the water
and  the pot is burnt for one and half an hour.
Properties and actions of Veeram
Characters :
Taste : Bitter and salty
Pontency (veeriyam) : Hot (Veppam)
Pirivu : Pungent
Bitter taste of Veeram has Earth + Fire elements.
It has got body improving tonic and antiseptic and ulcerogenic properties.
Panchabootha Amsam : Theyu
“ð£†®Q™ ªê£™½‹ ðFò£ù «îŒM«î”
According the Veeram is Appubootham in pasanathil  Panchapootham.
In Pasanapirivil Veeram considered as a theyu (fire) bootham.
Veeram is classified as a theyu sarakku in panchabootha sarakku and also the
karasarakku and peesasarakku.
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The following five have been specifically mentioned as Pancha boodha paadaanam
in the text “Pacchai Vettu 16”.
1. Earth - Prithivi : Arithaaram
2. Water – Appu : Savveeram
3. Fire – Theyu : Gowri
4. Air – Vayu : Vellai
5. Sky – Vinn : Lingam
“ÜKî£ó‹ H¼FM«ò ò£AGŸ°‹
Ýùªî£¼ êšió ñŠ¹ õ£°‹
ªðKî£ù ªè÷K«ò£ «î» õ£°‹
H¡Â«ñ£˜ ªõœ¬÷«ò£ õ£» õ£°‹
Ü¼ˆFò£ŒŠ ð„¬êòî£ ò£ì ô£°‹.”
However, in Nandheesar’s Kalaignanam the panchaboodha Paadaanas have been
mentioned in different way.
Fire – Theyu Veeram
Substances Antagonist to Veeram (Sathru sarakku)
Iron(Irumbu)Magnet(Kantham,)Tablesalt(kalluppu,)Potassium nitrate( Vediuppu),
zinc (Thuththanagam) Egg white(Muttai vellai karu)
Substance Synergetic to Veeram
Copper(thurusu)
Actions:
Alternative (udalthetri)
Antibiotic (Kiruminasini)
Anti-septic (Azhugal agatri)
Caustic (Punnundakki)
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General properties (Pothu gunam)
°¡ñªñ£¼ °†ìƒ ªè£®òõE ôˆFó†´
¶¡ñ£ƒ AêŠªð¼‚è… Å¬ô«ï£Œ & õ¡¬ñ»Á
è£IòŠ ¹‡ í£Fò «ï£Œ è‡ì£Ÿêš
ióªùÂ… ê£Iï£ ñˆ¬î»„ êK
Savveeram is used to cure the following disease
Gastric ulcer, leprosy, severe vadha diseases and morbid growth of flesh, throbbing
pain associated diseases ,venereal diseases ,bubo in the groins occurs to the female and
male due to forcefulness of sexually contact as explained in the above Tamil verse. This is
also for various types of eye diseases
Dose:
         2 - 4 mg
Dose above 4mg will be toxic.
Method of administration of Veera Jayaneer:
The perchloride of mercury and Ammonii chloridum (650 mg each) are taken and
dissolved in 500 ml. of purified water and ad­ministered upto 30 drops.
MAHAVEERA MEZHUGU
Group-A
Perchloride of Mercury 35g
Drumstick tree bark juice 1.3 lt
Group-B
Calmel 35gm
Cinnabar 35 gm
Ceylon leadwort root bark (Plumbago zeylanica) 210gm
Dried ginger (Zingiber officinalis) 35gm
Black pepper (Piper nigrum) 35gm
Long Pepper(Piper longum) 35gm
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Honey Required quantity
Mother’s milk Required quantity
Group- C
Saffron (Crocus sativus) 4.2 gm
Bezoar orientale (Korosanai) 4.2 gm
Crude camphor (Pachchai karpooram) 4.2 gm
Perchloride of mercury is consolidified by the drumstick tree bark juice through
heating and powdered. The ‘B’ group drugs are also powdered.
The A & B group powders are mixed well and triturated with the Ceylon lead wort
root bark with the required quantity of honey and mother’s milk. Finally group C drugs
are added and triturated well until it becomes waxy consistency and stored.
Dose
Equivalent to the size of 1-2 pulse grain
Diseases cured
Vatha diseases and venereal diseases.
Dietary restriction
Milk and rice.
VEERA MAATHIRAI (THIRI THODA MATHIRAI)
Purified Veeram (Perchloride of mercury) 1 Part
Pepper Seeds 4 Parts
Grind the both using pepper decoction and make the paste into pills of pepper size
and dried. If given with suitable adjuvants the diseases like fever caused due to the
derangement of three gunmams will be cured.
Instead of milagu decction, Nochi Surasam(Vitex negundo) is also used by which
running nose and shivering fevers are cured.
PRECLINICAL STUDY OF PAVALAVEERA CHUNNAM 12
SAVVEERA CHENDOORAM (Hydrargyri perchloride)
Take equal weight of Savveeram and borax (Vengaram), pul­verize them and heat
by putting it in a mud pan to get the chendooram.
 If given in sufficient quantity it cures, fever, delirium, blabbery, severe vatha
diseases, cholera, soolai etc.
SAVVEERA KATTU
Take 35 gms. of Camphor and put it in a mudpan (Agal) and put 35 gms of Savveera
upon it. Again put 35 gms. of Camphor over it and put into Lagu puda process using mud
cloth, and get the Savveeram of Kattu .
VEERA RASA PARPAM
Veeram (Perchloride of mercury) 10 parts
Cast Iron Powder 2 parts
Grind these two, by which rasam will come out, place the rasam in a mud pan and
add salt. Then put into mud-cloth puda process by which we can get white fine powder,
the parpam. Scrap the parpam and bottle up.
Dosage
488 mg  or required minimum quantity with jaggery.
VEERA NEER (For Local application)
65 mg .of  Veeram is mixed up with 240 ml. of water to get the Veera Neer. It is
used as a disinfectant and for cleaning the ulcers.
VEERA KALIMPU
4.2 gm. of Veeram is ground with 17.5 gm.of butter and the paste is used to cure
urticaria and to apply on the ulcers.
VEERA KALIMPU (AMIRTHA VENNAI-AMIRTHA MEZHUGU)
5.1 gm. of Saweeram is pulverized and ground with 350 gm. of butter for 6 hours,
and cleaned with water.
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It can be applied on die ulcers like Cancer or Carbuncle of chest
Clean the ulcers using the water boiled with tamarind leaves.
It is also used as local application on all swellings, boils etc.
It cures burning sensation in external piles.
As the Amirtha mezhugu contains more quantity of butter than Veera Kalimbu it
cures the inflammation.
JAYAVEERA RANA SINGI KAYIRU
Boiled oil 42gm
Vengaram(borax) 42 gm.
Veeram((Perchloride of mercury) 4.2 gm.
Black gram flour 8.4 gm
Grind these in a Kalvam adding rain water and make pills in wax stage and dry
them in shade. The colour may change from white into brown and which is harmless. It
should be used after one year.
Adjuvant Pure water
Usage
Ulcers, ringworm, pimples, syphilis, scabies, carbuncles, cancer of penis,
piles,scrofula,veneral ulcer,anorectal syphilis and different kinds of eye diseases.
OTHER PREPARATIONS
1 Veera sanjeevi mathirai:
Dose :Ulunthu alavu (65gms)
Indication :Sanny, Suram. Page 33
2 Maha koda surimathirai:
Dose :65gms
Indications: vettai, sanny ,visa noi. Page 38
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3 Veeraparpam  patchai vettu:
Dose : 50mgs-  3days- 6 times
Indications : Pun,vellai,kiranthi,katti,soolai . Page 46
4 Ramabana chenduram:
Dose : Arisi edai
Indications : Vayu,Veekam,Suram, Megam. Page49
5 Thanvanthri sandamarutha chenduram:
Dose : Pana edai -(480 mg)
Adjuvant : Honey
Indications : Sunny 13 ,kuttam,Mahotharam,Peeligai,Gunmam,
Vaginal cancer. Page 50
6 Vadha marutha melugu
Dose : Milagalavu
Adjuvant : Jaggery
Indications: Mudakku ,Vadham ,soolai,Pandu, Epilepsy,Parisavayu.
Page 54
7 Candamarutha cenduram:
Dose : Panavedei(480 mgs)
Adjuvant: Honey.
Indication 13 Sunny,Peeli, , vadham, Fistula, perumpadu
Anuboga vaithiya bramha ragasiyam
8 Veera paspam  :
Dose : Panavedei
Adjuvant : Honey
Indications : Sunny, Thosam, kabakatti,vayu.                   Page.505
Athmaratchamirtham
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Uses of Veeram
1 Veera jayaneer Dose 30 drops
2 Mahaveera mazhugu Dose 65 - 130 mgs
3 Veera mathirai (Thurthada mathirai)
Dose : Milagalavu
Adjuvant : Notchi decoction
           Indications : running nose, kulir suram,Fever
Saveera chendooram
Dose : 50-100 mgs
Indication : suram, sanny, pithavanthi, pedigai, soolai
Gurupathangam
Dose : 1/2 Arisiedai  (30mgs)
Adjuvant : Palm jaggery, Dry ginger paste
Indications : mehvayu, various types of ulcers, check cancer, soolai noi
Navalogamelughu
Dose : 1/2 -1 kundri  (65-130mgs)
Adjuvant : Palmjaggery, Dry ginger, Butter
Indications : Fever, Chunny, Mehanoi, Giranthi pun
Pattu karuppu
Dose : 2-4 Arisiedai  (130-260mgs)
Indications : Suram, mehasuram, oedema, epilogsy
                                                                      Anupagavaithiya navaneetham
External use of veeram
Veera neer 65 mg of veeram is mixed up with 240 ltr of water
Veera kalimbu Apply on the ulcers
Veera pugai 3 days and 6 times
Indication Giranthipum,Araiyapu non curable ulcers
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Pilavaikku pasai Apply on the carbuncles
veeram cures all types of the skin disease by the external applications
Anubava vaithiyam Dr Thirumalai nadarajan
Veera pugai Cures the oozing ulcers
Veera powder Cures the chronic ulcers
Venkarapodi
18 kuttam, thimir, snake bite, dog bite, ulcers,  piles, syphilis
Manjal karaseelai
Piles ,marpani, neerabeelai ,Thimir, karanai katti
Punpuraikku pugai
Dose 4.1 gms
Smoke curves soolai and ulcers
Moolam pavathiram punnukku pugai
Dose 4.1gms
smokes cures piles, fistula, ulcers.
Tholaiyu mennar sirodhararo(ªî£¬ô» ªñ¡ø£˜ Cˆîó«ó£)
          Kustarogam,  soolai, kai kal mudakku, pun, vadha karappan
Akkinipilasthiri
Ulcer curves  all types of ulcers.
Agasthiar Nayana Vaithiyam
signs and symptoms
The toxic symptoms of mercury choloride are Taste of verdigris, Ulcerative
stomatitis, Ulcerative gastritis, Vomiting, Watery diarrhea, Puffiness of face, Fissures on
the skin with serous fluid oozing, Morbid thirst, Hiccough, Syncope, Ptyalism, Ulcerative
laryngitis Dysphagia, Ulcers in the stomach, Dysentery, Pharyngitis, Throbbing pain in
the hypochondral region, Unconsciousness, Convulsions, Death
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Antidotes:
1. 20 ml. of Tribulus terrestris juice should be given to the victim in the morning and
evening daily.
2. Paste of the Indigofera tinctoria root bark in the dose of a size of Solanum pubescens,
dissolved in 80 ml. of lukewarm water should be consumed twice daily. Decoction
of the above drug is also given as an anti­dote for the poison.
3. 20 ml. of juice of Vemonia cinerea consumed twice daily which also acts as an
antidote.
4. This poison can be neutralized by drinking coconut toddy. Since the period of
treatment is not mentioned, all the above prescriptions can be continued til the toxic
effects disappear.
5. White yolk of the egg (unboiled) mixed with water or milk should be given often.
6. Tender coconut water also neutralises the toxicity of Mercuric chloride.
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VEERAM
3.1.2  GEOCHEMICAL  ASPECT
Terlinguaite is the naturally occurring mineral with formula Hg2clo. It is formed
by the weathering of other mercury -cotaining minerals. Discovered in 1900 in the Terlingua
district of Brewsher country.  The colour is yellow, greenish yellow brown or olive green.
Chemical name
Terlinguaite name in other language:
German Terlinguait
Spanish Terlinguaita
Tamil veeram
Hindi ‘ Sowweera pasaram
Sanskrit Sowweera
General
Chemical formula Hg2clo, (Hg2
2+) Hg2
2+ cl2O2
Category Mineral
Hardness 2.3
Strunz classification 3.DD.20
Crystal system Monoclinic
Unit cell  a = 19.51 Ao
b= 5.91 Ao
c  = 9.47 Ao
 = 143.81o
z  = 4
Ratio a:b:c
3.301:1:1.602
Unit Cell Value V 644.75 Ao3 (Calculated from unit cell)
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Identification
Colour Sulfur- yellow,greenish yellow, brown
Crystal habit Aggregates of equate to be elongated crystals,powdery,massive
Crystal Monoclinic - prismatic
Symmetry H-M symbol (2/m)
Space group : c2/c
Cleavage Perfect on [io1]
Tenacity Brittle
Mohsscale 2.5
Hardness  2-3
Luster Brilliant adamantine
Streak Lemon-yellow, turning olive - green
Diaphanelty Transparent to translucent
Special properties 9.22
Optical properties Biaxial (-)
Refractive index 2.350 =2.640 = 2.660
Birefringence  = 0.310
Pleochroism weak green and yellow 2v angle measured:20o
Alters  to  - turns olive - green on exposure to light
Classification of Terlinguaite
IMA Status : valid - first described prior to 1959 (pre - IMA) - “Grand fathered”.
                                                                                     : 3/D.06-10
                                                       - Nikel - Strunz 10th (pending)ed
3:DD.20
3:HALIDES
PRECLINICAL STUDY OF PAVALAVEERA CHUNNAM 20
D: Oxyhalides,hydroxyhalides and related double halides
D: with Hg
                                                                       - Dana 8thed  : 10.4.2.1
10: OXTHALIDES AND HYDROXYHALIDES
4: A2 (O,OH) Xq - Hey’s CIM ref : 8.5.3
8: Halides - fluorides, Chlorides , Brorrides and lodides also fluoborates and fluosillicates
5: Halides of Zn and Hg
Types occurance of Terlinguaite
Type locality:
Terlinguae district, Brewster co, Texus - USA Year of discovery   1900
Associated minerals at type locality
Montroydite Mecury,Kleinite Eglestonite Cinnabar,Calomel
Physical properties of Terlinguaite
Diaphaneity (Transparency) Transparent Transclucent
Lustre Adamantine
Colour: Yellow, yellow-green, brown (darkness to olive green on exposure to light),
pale olive green in transmitted light
Streak Lemon yellow, light yellow
Hardness (Mohs) 2-3 Gypsum - calcite
Tenacity Brittle - Generally displayed by glasses and most non-metalic minerals
Cleavage Perfect on { - 101}
Density 8.725g/cm3 (measured) 8.73g/cm3 (calculated)
Habit
Striated Parallel lines on crystal surface or cleavage face
Prismatic crystals shaped like slender prims (eg. tourmaline)
Magnetism Non magnetic
Luminescence Non - fluorescent
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General Terlinguaite information
Chemical formula Hg+Hg ++Clo
Molecular weight 452.63 gms
Empirical forumula HgHgClo
Environment oxidized portions of mercury deposits
IMA Status valid species (pre - IMA )1900
‘Name origin Named after its locality
Morphology
Crystal prismatic [010] and often somewith flattened on {001} rarely prismatic in
a pyramidal direction also equal dimensional or thick tabular {001} pulverulent; massive
aggregates of imperfect crystals (Dana 7thed 53)
Other information (Confirmation of Veeram)
 Turns black  immediately when treated with hydrogen sulfide
 Ammonia causes a slower change to black
 Decomposed with separation of calomel by acetic hydrochloric and nitric acids
Optical properties:
  Semitransparent
Colour lemon-yellow, canary-yellow, sulfur-yellow, becoming light   olive-green
on long exposure to light, amber - orange to nearly black   rarely zoned.
Streak very pale yellow
Luster Adamantine
Optical class Isotropic may be weakly
Occurrence Araresecondarymineralformedatlowtemperature in hydrothermal mercury
deposits.
Association Calcite cinnabar, metacinnabar, mecury, eglostonite, kleinite terlinguaite,
monotrydite, calomel, gypsum.
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Distrubution
 In the USA from Terlingura,Brewsher co Texas in the T.S clack Quicksliver mine
about 37 km northeast of lovelock fitt ing dist rict  mineral co and the MC
Dermitmine,Humbold co,Nevada from near the clear creak mercury mine New Idria district
San Benita co California.InMexio at Huahuaxtla,Guerrero and EI Doktor, Queretaro.
(veeram) Hg2 cl (or) HgclHg
TERLINGUIATE
Terlinguiate has been found with calcite, monotroydite and mercury and rarely
with eglestonite and calomel. The crystallized variety is with one exception, found only
on the calcite layer ,while the powdery form occurs on and in the pink matrix. The exception
referred to shows terlinguaite (with a little calomel) directly on the pink matrix. Apparently
there is no calcite present. The terlinguaite has not been found in closed in any other
mineral except that it is embedded, together with montroydite in calcite layer. The crystals
of terlinguaite sometimes in close mercury.
Crystal traces are resembled to monoclinic. In small striated prismatic crystals
elongated parallel to the b-axis many forms observed.
Cleavage perfect - (101)
Hardness 2 to 3
sp. Gravity 8.7
Luster Adamentine
Colour Sulphur - yellow changing to olive - green on exposure.prism crystals
Optically α – 2.35
 - 2.64
γ   -2.66
Strong disperstion , P<µ
Hg - deposits with calomel, cinnabar, eglastorite, kleinite
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Optical mineralogy:
Thin seat
Isometric H 2
Spy 8.33 - 8.56
Colour Pale yellow, Yellow brown
Handfree Yellow orange, yellow brown oxiolizezone Hgde....
Crystal faces Prism crystals, massive and powder
Savveeram similar to veeram pleochoic white to olive green colour.
 [Ref:DANA II 52.56]
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3.1.3 LATERAL RESEARCH ON VEERAM
Antibacterial Screening of Kodasuri Veeravaippu, A Siddha Salt Preparation
Accepted on: 06-03-2013; Finalized on: 30-04-2013.
Author : M. Sathish Kumar1, M.R.K.Rao1, A.Ganesan2, G.Rengasundari3
ABSTRACT
In siddha medicinal practice the use of plant extracts as well as inorganic natural
preparations has a vital role as medicines. Kodasuri veeravaiuppu is one such formulation
prepared by many inorganic compounds available in nature like Mercuric Chloride,
Mercury, Sodium Chloride, Rock Salt, Potassium alum, Ammonium Chloride, Oxides of
Calcium and Potassium, Copper Sulphate and Potassium Nitrate. It is proven medicine for
rheumatoid arthritis and as an antibacterial. The present study was to test the antibacterial
property of this drug on human pathogenic bacteria Bacillus cereus, Bacillus subtilis,
Proteous mirabilis, Citrobacter spp., Staphyllococcus aureus. Escheritia coli, Vibrio
chlorae, Salmonella typhi, Pseudomonas aeuriginosa and Klebsialla pneumoniae. The
results were encouraging when compared to standard drug Ciprofloxacin.
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PREPARATION AND STANDIZATION STUDIES ON VEERA MEZHUGU-A
SIDDHA ANTICANCER FORMULATION:
International Journal Of  Pharmacy and Pharmaceutial Sciences
ISSN-0975-1491                       Vol 6,Suppl 1,2014
Authors: P.RAJALAKSHMI, C.SAVARIRAJ SAGAYAM, P.BRINTHA
ABSTRACT
Veera mezhugu is a siddha drug formulation which is often prescribed in cancer
Theraphy.It  is a poly herbo-metalic preparation comprising Veeram(Corrosive sublimate)
Ra sam( Mer c ur y) Po o r am( Calo mel) Lingam( Cinnabar ) S uda m( Ca mpho r )
Sambirani(Benzoin) Perungayam(Asafoetida) Vediuppu(Potassium nitrate) Navacharam
(Ammonium chloride)Vengaram(Borax) Nervalam seed( Croton tiglium) and honey.In
the present work this anticancer  Siddha formulation is studied from process and product
standardization point of view.Physicochemical parameters are determined for the end
product as per Siddha Pharmacopoeia.Such kind of  standardization studies will contribute
in establishing  scientifically the merits of Siddha herbo-metalic preparations.
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3.2 CORAL
3.2.1 GUNAPADAM ASPECT
Zoological Name : Corallium rubrum (Linn 1758)
Synonyms:
Vithurumam,Thukir, Thuppu,Piravalam, Varithithandu, Senthandu maalai.
“æ˜‚«è£¬ô êƒèªñ£O˜ ðõ÷‹ ªð‡ºˆ¶
c˜Šð´ ºŠH«ù£ ¬ì‰¶”
õ£¼Fî‡´ õ÷˜‰î ªê‰î‡´ î£¡
«ï¼¶‚ ªè£®«ò£¡ «ï˜Hóõ£÷ ñ£ø
É¼¼ «õ¬÷ ê£ˆFò ªõ‡ñ£¬ô
ð£¼F ï£ñ‹ ðõ÷ˆF¡ «ð¼«ñ
-Sattamuni Nigandu -1200
¶Šðóˆî‹ Hóõ£÷‹ ¶A«ó & MŸðõ÷‹
Mˆ¶¼ñ‹ ¶õó‹
Namathepa Nigandu
“ðõ÷ˆF¡ «ð˜î¬ù«ò ðèó‚«èÀ
ð£ƒè£ù ¶A˜¶Š¹ Mˆ¶¼ðñ£°‹
¶õ÷ˆF¡ õ£¼F‚°œ î‡´ñ£°‹
²òñ£ù ªê‰î‡´ ªè£®»ñ£°‹
ðõ÷ˆF¡ MŸð¡ù‚ °÷ñ˜ˆî è¡Q
Üöè£è ê£ŸP«î£˜ ñ£¬ôò£°‹
°õ÷ˆF¡ Hóõ£÷‹ MŸðõ÷ñ£°‹
ÃPò«î£˜ °íªñ™ô£ƒ Ã˜‰¶ð£«ó”
-Bhogar nigandu 1200,
Ochi, Maamukku, Arasiya Antham, Uchithamadhu, Kamam, Thumbu, Lingam, Vadam,
Vangathusam, Vakkanam, Pathikadagam
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Above line says the coral is one of the marine products. It is one of the nine gems
and kadalpadu thiraviyangal.
As per Hindupurana, the muscles of velan fell down in the sea and become pavalam
during his battle with lord Indiran.-
The corals are the exo- skeleton of the minute marine organisms. The skeleton of
colories which are branched in all directions resemble tiny trees. These corals are found in
the deep seas like Indian Ocean and Mediterraneamsea.
Thiruvilayadal puranam explained how the Coral should be identified by
appearance. There are six good characters and six bad characters seen in pavalam depends
on its appearance.
Origin:
Malthevs, Laxathevs, Rameshwaram in India. Coral also get from Japan, Subathra
islands.
In Sambasivam Pillai Agarathi says, it is a band calcareous substance found in the
Ocean, secreted by marine polys for their common support and habitation. The stony
skeleton secreted by them continuously grows like plants which are called coral reefs.
Speciality of Coral:
Thirumoolar compared  Pavalam  with “Sakthi” (Lord Parvathy i.e. energy) and
sulphur (shakthi beesam)
He mentioned in his quotes as follows,
«îM »óˆ¬î«ï˜ ªêŠðô£°‰ ¶Š¬ð
ò£M Jóî«ï ó£° ñ¾ˆFè‰
«îM òó¡ dê… ªêŠ¹ I¬õè«÷
«îõ˜ ºîô£«ù£˜ «î˜õ K¬õè«÷.
As mentioned in Silapathigarm, the good coral should not be twisted porous and
must process bright red colour.
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Purification of pavalam:
1. Coral (35gms) is socked in 210gm of dates, toddy and insolated. Fresh dates toddy is
added on the next day and dried in sun light. This process is repeated for five times and the
material is washed in water to get it purified.
2.Coral is boiled in cow milk for 3 hours (oru saamam)
- Anubava Vaidhiya Kalanchiyam- page-286
3.Coralreef  is boiled in curd for 3 hours.
- Pallandu vazha payanulla Marunthugal - page 107
4.Coral reef is packed with a cloth and soaked in buttermilk and heated for one hour and
thirty minutes (4 Nazhigai)
- Yagopu vaidhiyam 300- page 16
Character:
There are six good properties and six defects in pavalam.
Good characters :
Chinduram, Semmani, Senkai, Muchumuchukkaikani, Veeraikkani, Thuthulai Kani.
Bad characters:
Pilavu, mudakku, Thirukal, Thulai, Karuppu, Veliral.
In Silappathikaram,
è¼Šðˆ ¶¬÷ò¾ƒ è™L¬ì ºìƒè½‹
F¼‚° cƒAò ªêƒªè£® õ™L»‹.
General properties  (pothugunam)
Coral gives shiny appearance to the body. It reduces phlegm, cough and loss of
appetite which occurs during the fever. It also counteracts the poisonous effect of insects.
It also controls thirst and improves spermato­genesis.
èó«î£ì‹ äòºˆ «î£ì²óƒ è£ê‹
Ü¼CW ìˆîô£‹ Ýô‹ & ªð¼Mˆ¶
ï†ì‹ ÜFî£è‹ ï£õø†C «ð£ªñ£O»ƒ
A†´‹ ðõöˆî£Ÿ «èœ
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Coral has also got diuretic, laxative and astringent properties. It also strengthens
the nerves. Further it reduces excessive phlegm.
The coral is useful in the treatment of pitha, excessive phlegm and eye disorders.
                                                    -Materia medica mineral animal kingdom.
Actions:
Expectorant - (Kabakari)
Nervine tonic - (Naramburamakki)
Astringent - (Thuvarpi)
Diuretic - (Siruneer perukki)
Laxative - (Malamilakki)
                                               Materia medica- (Mineral animal kingdom)
Emetic
Anti-bilious
Anti-Phlegmonous
                                                                 - Indian materia medica vol.II page-157.
In Pathartha soodamani,
¹¬óJô£Š ðõ÷ˆî¡¬ñ ¹è½«õ¡ ÞQ¶«è‡ñ£
²ó«ñ£´ õø†C Í„²ˆªî£Œõ¼‰ î£è‹«êì‹
Þ¼ñ«ô õ£îHˆî I¬íðò¬õ c‚°ªñ¡Á
õóñLºQõ˜ Cˆî˜õ°ˆî õ£èìƒèœ ªê£™½‹
- Agathiyar vagadam
¶A¬ó«ò Ü¿‚ªè£N‰¶ ¶Mîº‹ ð‡í£ñ™
õA˜õ¼õ¬ù òõ¡è‡ õQ¬î«ò ÞQ¶«è‡ñ£
àA˜ºQ Þóˆîè£ê‹ àŠðê‹õ™¬ô «ê£¬ð
ïM˜õî£ ªêŒc˜ H¡ù˜ïM™ªõù ªõ¡Áº¡«ù.
Coral reduce thirst, tasteless, tuberculosis, jaundice, fever, anemia, Poisonous effect
of insects, spermatogenesis.                         - Gunapadam kaiedu
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Dose :
3 - 12 grains - (200mg to 800mgs)
Thrice a day after meals. - Indian materia medica - page 157.
Preparation of Pavala parpam
1. The coral is triturated with latex of  Erukku (Calotropis gigantea) and kept in an
aghal and put to puda process to obtain the parpam.
2. Poultice of Ilandai (Zizyphus jujuba) or thaivelai (Gynandropsis pentaphylla) is
applied over the coral and kept in an aghal and put to puda process. It is then cleaned
with cow’s milk, insolate, powdered and taken.
3. The parpam can be prepared by using keezhanelli (Phyllanthus niruri).
4. The Coral could be triturated using rabbit’s blood and made into cakes and put to
puda process.
5. Equal quantity of coral and karpoora silajat triturated using juice of the vqjravalli
and put to gaja puda. The process is repeated with juice of Oxalis corniculata
(puliyarai juice)
6. Coral(20gm) and honey (120gm) are placed in a new mud pot. The pot is tightly
covered with a tile. A mud pasted cloth is made put and to pudam to get the parpam.
Pavala Chendooram:
Coral (35gm) is triturated individually with the following juices of palmyra, cotton
(Gossypium herbaceum), Viola suffruticosa, Daemia extensa, Arecanut and wild chinchona.
It is then subjected to puda to ob­tain chendooram.
This chendooram is effective in the management of piles, burning sensation of
head and hand, abdominal pain,tremors and diarrhoea
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Pavala Chendooram:
Adjuvants Indications
1. Hot water Bleeding haemorrhoids
2. Sugar Fistula
3. Ghee Burning sensation of head and hand
4. Juice of Allium cepa Peptic ulcer with vomiting
5. Panagam Tremors
6. Water Morbid thirst
7. Liquorice Soothaka Sanni
(Glycyrrhiza glabra)- A dhimaduram
8. Cajanus cajan leaf juicefPigeon pea) Abdominal pain
9. Crataeva religiosa Diarrhoea
Adjuvant : Honey,Ghee.
Indications: Piles, burning sensation of head and hand, abdominal pain, tremors and
diarrhoea.
Other preparations
Pavalaparpam
Dose : -3 Kuntri (65 – 400mgs)
Adjuvant : Ghee, Honey
Indications : Kannoi, Uppusam, Vamiting, Vallaikatti, Asicitis,
 Page - 127
Pavala parpam
 Dose : to 3, Kundri(65-400mgs)
Adjuvant : Coriander leaf  juice
Indications : Dysentery, Pitha Noi.
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Pavala parpam
Dose : 1-4 Kundri (130 - 520mgs)
Adjuvant : Butter,
Indications : Manneeral veekkam (splenomegaly) ,diarrhoea
Pavalaparpam
Dose : 2 -4 kundri (260-900mgs)
Adjuvant :Butter, Ghee
Indications : Cough, TB, Pithanoi, Vettai
                                                 -Anuboga vaithiyanavaneetham (Hakkim) 3rd part
Karuvanga chenduram
Dose : 2 - 4 Kundri (260-900mgs)
Adjuvant : Suitable one
Indications : Vettai  Noi, Meha Noi
              Anubopa vaidhiyam  - page - 83
Thirilokkia chinthamani
Dose :1 varagan (3.5gms)
Adjuvant : Honey, Pepper, Ginger juice, Dryginger water
Indications : Kavisai, Soolaikattu, Anemia, Abdominal Pain, Asicits, Fistula.
  Epilepsy
                                                  -Eliya vaidhiya muraikal (S. Prema) - page 248
Pavalaputru Parpam
Dose :2-4 kundri(260-900mgs)
Adjuvant : Elanthiver, Elanthai palam
Indications : Menorrhegea
                   -Anboga vaithiya murai Dr. C.N. Kuppusamy -page 40
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Rajamirugangam
Dose : 520mgs
Adjuvant : Pepper, Honey
Indications : Reduce body heat
Vasantha Kusumaharam
Dose : ulanthu alavu (65 mg)
Adjuvant : Honey, Jaggery, Ghee
Indications : Anemia, Dysentry, Soolai, Piles, Meharogam, Chest pain, TB,
Page – 99
Eraniyakarppam Rasam
Dose : Ulunthalavu (65mgs)
Adjuvant : Suitable one
Indications : Vadha, Pitha, Kaba and Thontha suram Page – 120
External uses
Thumalaravu vellaipravalathi Mathirai
Adjuvant : Nanthiyarathi juice
Indications : Eye disease  (Nethrarogam) Page - 67
Sethupandithar Rathinathi mathirai
Adjuvant : Breast milk,
Indications :Eye diseases
Rathinathi mathirai
Adjuvant :Brest milk (or) Palm leaves juice
Dose : Venthayam Alavu.
Indication : All eye diseases - Thimiram, Kasam, Padalam, Sukkan,
  Ranasukkiran, Pillam
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CORAL
3.2.2. ZOOLOGICAL ASPECTS
Classification
Kingdom - Animals
Sub-kingdom - Radiates
Infra-kingdom - Coelenterata
Phylam - Cridaria
Class - Anthozoa
Sub-class - Alcynoaria (octocoralia)
Order - Gorgoncea
Family - Corallidae
Genus - Corallium
Species - rubrum
ZOOLOGICAL NAME
Corallium rubrum (Linn 1758)
SYONYMS
Madrepora rubra (Linn 1758)
Isis nobilis
Gorgonia nobilis (Linn 1789)
www. sn2000 taxonomy.nl/main/classified
Meaning of Coral
v  A rockline deposit consisting of the calcareous skeletons secreted by various marine
inverstebrates.Chiefly anthozoans,coral deposits often accurate to form reefs or island in
warm sees.
v  A polyp or colony of polyps of any of the numerous anthozoans that secrete a hard or
flexible skeleton espacially the reef building hard corals.
v  A polyp or colony of polyps of any of various hydrozoans that secrete hard skeletons,
such as the fire corals.
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v  The hard skeleton of various corals espacially of red corals of the genous corallism
used to make Jewellary and ornaments.
In Zoological view.
Any marine mostly colonical coolenterate of the class on the zoo having calcareous
horny or soft skeleton.
Coral are invertebrates like shallfish they have no spinal colounm or internal bones.Coral
colories are composed of many tiny cup-shaped animals called polyps.Millions of polyps
working together in a co-operative.Colony generation after generation create the limestone
skeletons that form the framework of the beautiful reef.
Corals losely defined include stony corals otocorals.Black corals and hydro
corals,constituting  approximately 4820 species.65% of those species or about 3,150 occur
in deep water.
There are two general types of corals
* Hard Corals
* Soft Corals
Hard Corals
Hard corals usually grow in large colonies and make up coral reefs.They create
skeletons out of limestone. Which eventually becomes the rocky structure most of us are
familiar with hard corals survive on tiny algae and sometime small fish like plankton
when people talk about “coral” they are usually taking about hard corals.
Soft Coral
Soft corals often seem like plants or trees.These intestesting corals don’t have
stone like skeletons they have woody cores and fleshy rinds for protection.They are non-
reef building corals and don’t necessarily need algae to survive.They ‘re  naturally found
in a variety of climates both tropical and cooler regions.Many soft corals are very easy to
keep and are suitable for a beginner tank.
Varieties of coral:
Many varieties of coals are like red corals,black corals,white corals,blue corals,
soft corals,stony corals,horny corals,pepper corals and organ pipe corals
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Types of corals:
1 Pillar coral:
Scientific Name: Dendrogyra Cylindricus
2 Stagborn coral
Scientific Name:Acropora cervincornis
3 Sea pen
Scientific Name: Pennatulacea
4 Coenthecalia (Blue coral)
Scientific Name: Heliopora coerulea
5 Elkborn coral:
Scientific Name: Acropora palmata
6 Leptosammia
Family: Dendrophylidae
7 Antipathes (Black coral) - 100 species
Scientific Name: Antipathes
8 Great star coral(stony coral)
Scientific Name: Monokastrace cabernosa
9 Colpophllia natans’
Scientific Name: Colpophyllia natans
10 Diploria strigos
Scientific Name: Diploria strigosa
11 Eusmila (Stony coral)
Family: Meandrinidae
Coral reefs:
Coral reefs are diverse underwater ecosystems held together by calcium carbonate
structure secreted by corals.Coral reefs are built by colonies of tiny animals found in
marine waters that contain few nutrients.Most coral reefs are built from stony corals,which
in turn consist of polyps that cluster in groups.The polyps belong to a group of animals
known as cridaria,which also includes sea anemones and jellyfish.Unlike sea
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anemones,corals secrete hard carbonate ecoskeletons which support and protect the coral
polyps most reef grow best in warm shallow, clear sunny and agitated waters.
Often called “Rainforest of the sea”shallow coral reef from some of the most diverse
ecosystem on Earth.
Types of coral reefs
Most reef scientists generally recognize three major types of coral reefs
1 Fringing reefs
2 Barrier reefs
3 Atolls reefs
1. Fringing reefs
They are reefs that grow directly from a shore while there may be areas of shallow
intertidal or sub-tidal sand bottom lying between the beach and the inshore edge of coral
growth there is no lagoon between the reef and shore.
2 Barrier reefs
They are extensive linear reef complexes that parallel a shore and are separated
from it by lagoon.
Barrier reefs are far less common than fringing reef or atolls although examples
can be found in tropical Atlantic as well as the pacific.
The 1200 mile long great barrier reef of the NE coast of Australia the word largest
example of this reef type.
3 Atolls
An atoll is a roughly circular(annular) oceanic reef system surrounding a large
(and often deep) central lagoon.In the south pacific most atolls occur in mid ocean.
Atolls are usually circular or oval in shape,with an open lagoon in the center.
Other  Types of reefs
Apron reef
Patch reef
Ribbon reef
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Table reef
Platform reef
Coral reef can take a variety of forms as the following
Apron reef
Short reef resembling a fringing but more sloped,exhending out and downward
from a point or penisular shore.
Patch reef
An isolated,often circular reef,usually within a lagoon or embayment.
Ribbon reef
Long narrow some what winding reef usually associated with an atoll logon.
Table reef
Isolated reef approaching an atoll type but without a lagoon.
Platform reef
Usually lie in sheltered seas and quite for affshore.They are flat-topped with small
and very shallow lagoon.
Formation of coral reef
The animal nature of coral reef was established in 1927.Present reef budding corals
donot grow below 50 meters.Geological evidence indicates that the coral polyps of the
past ages were also littoral in their habits.Several theories were propound in the past to
explain the mystery of origin of coral reef and atolls of which the following are the chief
ones.
1 South buryra valcanic crater theory
2 Darwin’s Dana substance theory
3 Semper’s Murray solution theory
4 Doly clacial control theory
The idea of an aribecatant platform of foundation is necessary postulation for all
coral growth.As there are many kinds of such foundations and many many geological
phenomena forming them,it is natural that no single thorey can account for all the cases
reef formation.
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Age of the coral reefs
Most reefs grew at the rate of 10-200mm each year.Most of the existing reef could
have been formed within a period of 15000 to 30000 years.
Composition of coals
Cao Mgo Sio2 Loss on ignitiam
Hydroza Alcicorris 52 0.43 0.23 44.77
Actinozoa poritec Astreoides 53.84 0.18 0.02 44.98
Madrepora prolifera 53.48 0.06 0.19 44.50
Favia fragum 53.69 0.18 0.28 44.44
Maeandral abyrinthiformis 53.71 0.26 - 45.10
Physical properties
Density 2.60 and 2.70 gml cm3 (usually)
Refractive indices nz 1.49
nv 1.65
Hardness 2.5 j 4 according to mohsm scale
Constituents
Animal (or) organic matter 8%
Carbonate of lime 83%
Magnesium carbonate 3.5%
Oxide of iron 4.5%
The red colour is due to its containing iron.
Ref : Indian meteria medica Dr KM Nadharri
Medical uses:
Pseudopderosin found in a caribbean gorgonian coral. This chemical is used in a
cream that protects the skin from weather damage .It also is being investigated as an anti
inflammatory for we in conditions such as prosiasis and contact dermatitis.
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3.2.3. LATERAL RESEARCH ON CORAL
ANTIBACTERIAL AD HAEMOSTATIC ACTIVITIES OF A SIDDHA
FORMULATIO – PAVALA PARPAM
Pharmacologyonline 1: 613-624 (2011) Thanigavelan et al.
Author Thanigavelan.V,Victor Rajamanickam.G.Kaliyamurthi.V,Lakshmanakumar.V,
Sasikala.N andThirunavukkarasu.S.V
Background: Pavala Parpam (PP) is a traditional Siddha medicinal preparation.
This marine sourced medicine is synthesized through calcination of Corals as narrated in
the classical Siddha literature – Anuboga Vaidhya ‘avaneetham. This literature evident
shows that Pavala Parpam has astringent action and becomes evident in arresting bleeding.
The primary objective of this work was to validate the safety and haemostatic efficacy of
PP. Methods: The raw Pavalam were procured from country drug store at Marthandam,
Tamilnadu and purified by the traditional procedure by soaking in lemon juice for 24 h
and the test drug PP was prepared by the process of Pudam (Calcination) described in
Anuboga Vaidhya Navaneetham 3rd part, page no: 132-133. Adrenochrome and other
analytical grade chemicals were procured from Sigma chemicals, U.S.A and S.D fine
chemicals Ltd, Mumbai. The experiments include preliminary biochemical studies by
standard methods, quantitative analysis of Calcium by AAS, antibacterial studies by paper
disc diffusion method, acute oral toxicity study under OECD 423 guidelines, and the
haemostatic effects of PP in Albino mice including shortened bleeding and clotting time
efficacy on by the method described in Ogle et al.,1977. Results: The qualitative and
quantitative analyses of PP show that it has the contents of 37.48% of calcium, ferrous
iron, tannin, and tannic acid. These compounds have the property of Haemostatic action.
In vitro studies, Pavala Parpam has good anti microbial activity at the dilution of 25
microlitre/disc against the bacterial strains such as S.mutans, S.aureus, E.coli, K.pneumoniae
and P.aeruginosa. Animals were found to be safe up to a maximum dose of 2000mg/kg
body weight in acute toxicity studies. The experimental studies done on animal model,
Pavala Parpam shows potent Haemostatic action by exhibiting significant reduction
(P<0.001) in bleeding time and clotting time of blood compared with control group.
Conclusion: Pavala Parpam is the safest and efficacious haemostatic drug comparable to
Adrenochrome – a standard drug.
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3.3  BILE
3.3.1 GUNAPADAM ASPECTS
The biles of animals such as cow, buffalo, goat, deer, pig, dog, cat, peacock, fish
and snake are used as medicine.
Bile has got laxative property. It is used to triturate the vairava pills which are
useful for treating the diseases like delirium. It is effective in the treatment of white leprosy
and is used as follows:
Process :
Vernonia anthelmintica (kaattu cheeragam) and dried leaves of Fumaria parviflora
(thara) are taken in equl quantities. Chooranamis made and placed in a mortar. The goat’s
bile is then added and ground for four days and pills are made in the size of a strychnos
potatorum (thetran) and dried in shadow. Pills are taken
Dose :
Twice daily for three months.
Uses :
It is also applied topically.
It is also useful in the purification of steel.
Dried root of Trianthema decandra (saththi chaaranai) is placed in goat’s bile.
The root is rubbed in the flower juice of Tabernaemontana divaricata (nanthiya vattam).
When the juice is used as eye drops 96 types of eye diseases are cured.
Siddha Medicines prepared from bile
Ananda bairavam Snake bile
Karavala vairavam Dog bile
Karunya vairavam Pig and peacock bile
Sannipatha vairavam Buffalo,Peacock fish bile
Siddha vairavam Fish bile
Boothavairavam Cot bile
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Madhanavairavam Cow bile
Manokaravairavam Donkey bile
Vidhana vairavam Deer bile
Vijaya vairavam Dog bile
-Siddha vaithiya thirattu
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3.3 BILE
3.3.2 ZOOLOGICAL ASPECTS
Bile is a digestive juice that is secreted by the liver and stored in the gall bladder. It has
two important functions.
 Assists with fat digestion and absorption in the gut.
 Is a means for the body to excrete waste products from the blood.
 Bile does not contain enzymes like other secretions from the gastrointestinal tract.
Instead it has bile salts(acids) which can.
 Emulsify fats and break it down into small particles. This is a detergent like action
of bile.
 Helps the body absorb the breakdown products of fat in the gut. Bile salts bind
with lipids to form micelles. This is then  absorbed through the intestinal mucosa.
 The other important function of bile is that it contains waste products from
hemoglobin break down. This is known as bilirubin and is normally formed by the body as
it gets rid of old red blood cells which are rich in hemoglobin .Bile also carries excess
cholesterol out of the body and ‘dumps  it into the gastrointestinal tract where it can be
passed out with other waste matter.
Composition of Bile
The bile of man and carnivorous animals is of a deep orange red colour,turning of
greenish brown  by decomposition of its colouring matter. In herbivorous animals it has
some shade of green when quite fresh.But turns to a muddy brown after a time. It is
transparent and more or less viscid according to the length of time it has remained in the
gall bladder. It has an alkaline reaction. Its specific gravity is about 1005 when taken from
the bile ducts directly, but it may rise to 1030 after prolonged stay in the gallbladder owing
to the  addition of mucus and the absorption of time of its fluid.
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Approximately the proportions of the chief constituents of bile:
Water 85.0 percent
Biesalts 10.0"
Colouring matter and mucus 3.0"
Facts 1.0"
Cholesterin 0.3"
Inorganic salts 0.7"
Total 100.0
Bile contains no structural elements nor any trace of aluminous bodies.
* Lecithin
* Sodium
* Potassium
* Calcium
* Chlorine
* Bicarbonate ions
As mentioned, gallbladder bile is concentrated compared to liver bile. Bile salts
make up the largest volume of gallbladder bile and can be  6 times more concentrated than
bile salts in liver bile.
Metabolic Functions
Emerging evidence associated FxR activation with alternations in  triglyceride
metabolism  glucose metabolism and liver growth.
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3.3.3 LATERAL RESEARCH  ON BILE
BILIARY SECRETION IN SUCKLING GOATS: THE EFFECT OF
MATERNAL MILK AND OF A LAMB MILK REPLACER
Archives of Physiology and Biochemistry 1381-3455/96/10402-0239
1996, Vol. 104, No. 2, pp. 239-245 © Swets & Zeitlinger
Author A. Rueda, A. Valverde, J.A. Fernandez, E. Martinez-Victoria, J.A. Naranjo and
M. Mañas
                                                ABSTRACT
A total of 45 preruminant goats were fed either goat milk or a milk substitute. The
postnatal development of bile secretion and biliary lipids composition of suckling goats
and the influence upon these parameters of maternal milk substitution were studied during
the first month of life. Samples of hepatic and gallbladder bile were obtained from kids of
1, 7, 14, 21 and 28 day-old. Bile flow rate, cholesterol, total bile salts and phospholipids
were measured.
Our results show that the quality of the protein and fat used in the elaboration of
the milk replacer, affects the evolution of both hepatic bile flow and biliary lipids
composition. Differences between gallbladder and hepatic bile composition show a scarce
concentration capacity of the gallbladder with both diets and at all ages studied.
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CHUNNAM
3.4  PHARMACEUTICALS  REVIEW
Definition :
The word ‘Chunnam’ indicative of an alkaline product, similar to lime. In Tamil
language, Caustic lime is also turned as Chunnam. The word denotes which colour (chun)
lime (chunnam) fine particle and calcined paste.
Raw meterials in chunnam preparation:
Many metallic and non metalic mineral drugs are made into chunnam preparations.
Metals : Gold (Thangam) Silver (Velli) Copper (Chembu) Iron (logam) Zinc (Naagam)
lead (karuvangam)......
Mercurials and other toxic substance : Mercury (Rasam) Cinnabar (lingam) Calomel
(Pooram) Mercuric perchorid (veeram) thalagam (As2S3).
Salts (karasaram):  fuller’s earth (Pooneeru) salt peter (vediuppu) Camphor (Karpooram)
Kalluppu (salt)........
Mineral  origin : (Uparasam) Mica (Abrakam) asbestos (kalnar) Copper Sulphate (thurusu)
Chalcopyrite (nimilai).......
Zoological product : Kizhinjal (conch shell) Sangu, nandu odu, nathai odu, Muttai odu.
Equipments required :
: Mortar and pestle
: Vessels and spoons to handle liquids.
: Long ribbons of tough cloth and fine clay.
: Pairs of shallow earthen discs of identical dimensions.
: Cow dung cakes, sufficient numbers and well dried.
: Fine cloth pieces for filtering juices and decoction.
: Spatula for handling powders.
: Air tight containers.
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General Method of preparations :
The above naturally obtained ingredients are processed sequentially by elaborate
processes like grinding melting, triturating, quenching in different plant juices with different
heat treatments thus changing form from one to another and in the end, making into bio-
available form.
Chunnams are prepared by two different methods one is simple and another is
complex. Chunnam should be prepared during the hot. Summer months like April and
May .Simple, Complex Method, Crucibles (Moosai) used in Chunnam.
Simple Method
In this method either lime stone or calcium group of raw materials are subjected to
calcinations or incineration in pudam method with cow dung cakes as specified in the
formula. Commonly these medicines are used extensively by physicians; examples are
chunnam of salt peter (vediuppu chunnam) and chunnam of egg shell (anda odu chunnam),
which are used extensively in urinary, genital disorders and in acid peptic diseases.
Complex Method
A very systematic, elaborate, stepwise procedure is followed in these preparations.
High metals, gems or any toxic material is detoxified as per recipe and then converted it to
a fine homogenous substance by triturating with plant juices or some distillates called
pugai neer or thiravagam or with any solvent (jeyaneer)and made into fine paste and are
well dried. Tins paste is kept in distinct, specially made crucibles called moosai like Pancha
chunna gugai and sealed. After drying, this crucible is heated in a hand bellows blower.After
sufficient heating, generally up till a point when the crucible becomes red hot and itself
gives-up its structure. The contents are allowed to cool and collected. The final product
after sufficient grinding
Crucibles (Moosai) Used iu Chunnam
It is very interesting to note that heat resistant crucibles (moosai/ gugai) are specially
made prior to chunnam preparation Special crucible called pancha chunna gugai is prepared
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with chunnam of crab shell (nandu).fresh water shell (nathai). conch shell (sangu). pearl
oyster shell (chippi). egg shell (anda-oodu). latex of Calotropis  erukkampaal;. egg albumin
venkaram and lime water (chuunna neer). Anju chunna gugai..pancha butha gugai are
few other crucibles particularly used for chunnam preparation.
Product Grades
The chunnam of many metal and non metal drugs are graded according to the
solvents used in the preparation, the type of crucibles used and type of heating appliances
used in the process of particular preparation. If the chunnam is prepared in pancha cnhuna
gugai and incinerated with bellows blower is graded as best quality. If the chunnam is
prepared with fuller’s earth- (pooneeru chunnam) the drug is graded as second quality. If
chunnam is prepared by the use of copper sulphate chunnam (thuiusu gum chunnam).it is
classified as third quality. If chunnam is prepared with caustic solvents like jayaneer. This
variety is classified into 4th quality. Generally physicians prepare a special kind of solvent
called chunna thiravagam to prepare all kinds of chunnam of salts, minerals, metals and
various gems.
Shelf Life
When properly stored, they retain then potency up to 500 years.
Adjuvant - Anupanam
It is advised to take the chunnam medicine with ghee, butter or milk. Dosage is
indicated according to the disease condition as 3 days or 7days or 21days.
Colour :
Chunnams are in powder form and generally soft white to ivory color or colourless.
If white color is not obtained fuller’s earth chunnam is added to get the white
colour .
Character and tests for chunnam:
Chunnams are odorless, lusterless, smokeless on heating.
Microfine in particle size wafer like very light in cut
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The end point on purity of chunnam is ascertained by adding a pinch of turmeric
with few drops of water it turns turmeric from yellow to red perhaps as on indicater of the
PH value.
           Chunnam also testes like lime and will produce irritation when it comes in to contact
with mucous membrane. Kadunkara Chunnam is highly alkaline caustic and blisher
forming.
Preservation and storage:
Chunnam should be kept in dry well stoppard glass bottles.
Uses of Chunnam
Generally chunnams are acclaimed as best possible medicaments in chronic
degenerative human ailments with various adjuvants. Chunnam of salt peter, which is
called as vediuppu chunnam, is used extensively by present day physicians in miliary
disorders especially on urinary calculi, and in some types of malignant and non malignant
tumors.
Chunnam of borax which is called as vengara chunnam are highly preferred in
metabolic disorders of liver and spleen diseases. Many of these chunnam preparations
play a vital role in the process of higher order medicines called Kattu (solidified metals).
One of the best examples is solidified mercury called sootha kattu.
Among various chunnam preparations a very few preparations are considered very
indispensable as medicine and in medicine preparation, are termed as Guru chunnams.
Very few dings like gold, silver, copper sulphate, fuller’s earth chunnam preparations are
considered as gold chunnam and termed as thanga guru, velli guru, thurusu guru, muppu
guru respectively.
Among the many uniqueness of Siddha medicine, kayakalpam or rejuvenation
therapy is its epitome. Food and life style modifications with ding therapy are indicated in
this line of treatment. Muppu chunnam is basic and cardinal component in these preparations
of anti ageing processes and also in alchemical transformations.
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Apart from this, muppu chunnam is also used as an adjuvant for many medicaments for
chronic degenerative diseases and is a purifier of metals and minerals.
Many chunnam preparations of sal ammoniac (kambi navachara chunnam).borneo
camphor (kaipoora chunnam).copper sulphate (thurisu  ).arsenic thalaga chunnam:(vanga
chunnam). copper (thamira chunnam), gold (thanga churmami. mercury (rasa chunnam).
mercuric per chloride ( veera chunnam). mica (abrakam). magnetic ore (kantham iron -
aya chunnam)  arsenic oxide sulphide (gowri). sulphur (gandagam). cinnabar (lingam).
zinc (nagam) are prepared with muppu chunnam
It is worth mentioning that very small quantity of copper sulphate chunnam (thurusu)
is added to extract juices or latex from very dry natured plants like virali(Dodonea riscosa).
kuppai meni (Acalipha indica) and erukku(Calotropis gigandica)
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3.5. DISEASE REVIEW
KALLERAL NOI
3.5.1 SIDDHA  ASPECT
Definition:
Damage of Liver cells or decrease or loss of Liver function or enlarge in size of
Liver is called Liver disease.
Synomyms:
Valapattu eral noi,Manthakatti,Kalmantham,Yakkutham.
Aetiology:
D Excessive intake of food
D Alcoholism
D Obesity
D Associated with fever
Symptoms:
D Tastelessness
D Excessive of secretion of saliva
D Loss of appetite
D Indigestion
D Bile vomiting in morning
D Nausea,vomiting
D loss of weight
D Frequent fever
D Oedema in abdomen
Classification:
1 Vali kalleral noi
2 Azhal kalleral noi
3 Aiya kalleral noi
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Vali kalleral noi symptoms:
D Weight loss
D Blackish skin colour
D Ascites
D Enlarged lymph nodes
D Anemia with oedema
Azhal kalleral noi symptoms:
D Decreased in Liver function
D Yellowish discolouration of the skin
D Bitter in taste
D Vomating
D Oedema
D Ascities
Aiya kalleral noi symptoms:
D Itchy skin
D Swelling in the ankles and abdomen
D Abdomal pain & Bloating
D A brownish or orange - colour urine
D White stools
D Confusion disorientation, personality changes
D Blood in the stool
D Fever
MANJAL NOI
Definition:
Manjal noi refers to the yellowish discolouration of skin, Sclerae, mucos membrane
and urine. Due to increased pitham and its complications.
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The term kamalai is self explanatory refers to the meaning desirelessness or
disinterested state due to any underlying cause whatever. The word kamalai is formed by
the following two words.
Kamalai = kamam +illai
Therefore,there is no desire interest and ability neither with his daily activites nor
with all other things including sex. Many causes can develop such condition. But Yugi out
of  his knowledge has classified this kamalai into 13 types as per the convenience of
treatment method and symptomtology.
A group symptoms and signs when able to be treated by a group of medicine or a
single medicine has been classified into a type. Thus according to predominant symptoms
and therapeutic convenience 13 such types are classified by YUGI .V
Synonyms:
Pitha Noi, Manjal noi,  kamalai, kamala, Kamila
Aeitology:
The three humors are responsible for the normal physiological conditions of the
body.If any of these factors increase or decrease from its normal ratio.It leads to pathological
changes in the body and thus produces disease.
According to “Yugi - 800” the kamalai is caused by the following conditions
“M÷‹ð«õ ð£‡´ ºŸP¼‚°‹ «ð£¶
eP«ò Hˆîõv¶î¬ùŠ ¹Cˆî£™
¹÷‹ð«õ ñƒ¬è»ì¡ ¹í˜„C ªêŒî£™
Ì‡®´«ñ è£ñ£¬ô ªò¡Â‹ «ó£è‹”
1 Taking pitha substances when suffering from pandu.
2 Having excessive sexual intercourse.
3 Excessive intake of food.
4 Sleeplessness during in right time.
5 Excessive intake of highly spicy  food items.
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Signs and Symptoms:
“ð¼è«õ àœ÷ƒè£ ½œ÷ƒ ¬èèœ
ðè˜ºèƒè‡ µì‹¹Iè ªõÀŠ¹ è£µƒ
è¼è«õ è£™¬èè «÷£Œ„ê ô£°ƒ
èùñ£ù ï´‚A«ò Þ¬÷Š¹‡  ì£‚°…
è¼è«õ ñô˜‰î£Â‹ õø‡´ è†´‰
Éòºè ñ…êOì Gøñ î£°‹
ªõ¼è«õ i‚èñ£Œ‚ è¬÷Š¹‡ ì£°‹
I‚è£¶ ñ‰î‰î¬ô èùŠ¹‡ ì£°‹”
pallor of sole, palm, face, eyes and body.
Lassitude
Generalized malaise
Shivering
Dry stool and constipation
Yellow discolouration of face, oedema, fatiquability
Heaviness of head
Excessive salivation
Nausea
Bitter taste
Dryness of skin - frog like skin
Yellow discolouration of eye, nailbud, skin, tongue and urine.
Classification:
According to the medicine and convenience various siddhars have classified this
disease kamalai in their own style.
In  ‘Thanvandri vaidhyam’kamalai is classified into 5 types
In ‘Agathiyar 2000’ kamalai classified into 8 types another one is based on diseased
wise
According to T.V Sambasivam pillai dictionary classified into 16 types
In Balavagadam it is classified into 3 kinds,
1.Oothu kamalai        2.Manjal kamalai           3.Varat kamalai
PRECLINICAL STUDY OF PAVALAVEERA CHUNNAM 55
In our Pothu maruthuvam, it is classified into 13 types. They are,
1 Vali kamalai
2 Uthu kamalai
3 Varat kamalai
4 Azal (or) Pitha kamalai
5 Aiya (or)kapa kamalai
6 Vadha kapa kamalai
7 Azhalaiya kamalai
8 Mukkutra kamalai
9 Azhaku kamalai
10 Senkamala kamalai
11 Manjal kamalai
12 Kunma kamalai
13 Kumba kamalai
Naadi:
“ð‡ð£ù HˆîˆF™ «êˆ¶ñƒÃ® ðKCˆî£™
è‡è£¶ ñôc¼ ñ…êœ....”
Management:
Purgative (kalichal)
Emesis (vanthi)
Avoid Tamarin and  salt
Avoid oily and fatty foods
Add
Rice kanji, Tender coconut water, sugarcane juice, Tender vegetables, greens.
Dairy products
Cow’s milk, goat’s milk,
Non-vegetarian diets - Ayirai meen (loach).
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3.5.2 MODERN ASPECT
LIVER DISEASES
Definition
Liver disease is any disturbance of liver function that cause illness. The  liver is
responsible for many critical functions within the body and should it become diseased or
injured, the loss of those function can cause significant damage of the body. Liver disease
is also reffered to as  hepatic disease.
The liver can be damaged in a variety of ways
Cells can become inflamed for example hepatitis.
Bile flow can be obstructed for example cholestasis.
Cholesterol or triglycerides can accumulate for example steatosis.
Blood flow to liver may be compromised
Liver tissue can be damaged by chemicals and minerals or infiltrated by abnormal
cells like cancer cells.
Liver disease comprise vast range of condition that affect the normal functioning
of the liver. The symptoms related to the liver dysfunction include both physical signs and
a variety of symptoms related to digestive problemcoagulapathies, blood sugar problems,
immune disorder, abnormal absorption of fat and metabolism problems.
There are more than 100 kinds of liver disease like hepatitis, alcoholic disease,
fatty live disease, cirrhosis hereditary disease, hepatic encephalopathy ,Acute liver failure,
Haemochromatosis and liver cancer.
Cirrhosis of the liver:
Chronic liver damage from a variety of causes leading to scarring and liver failure.
Alcoholic hepatitis
Liver inflammation caused by drinking too much alcohol.
Hepatitis A
A highly contagious liver infection caused by the hepatitis A virus.
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Hemo chromatosis
Hemochromatosis (iron overload) is a metabolic disorder that leads to abnormally
evelated iron stores in the body. The excess iron may accumulate in the tissues of the liver,
pancreas and heart and can lead to inflammation hemachromatasis is an inherited disease.
Alcohol abuse:
Alcohol is directly toxic to liver cells and can cause liver inflammation, hepatitis.
In chronic alcohol abuse, fat accumulation occurs in liver cells affecting their ability to
function.
Fatty liver develops in about 90% of individuals who drink more than 60mgs/day
of alcohol. About 5% of the population can cause mild jaundice.
JAUNDICE
 1 A medical condition with yellowing of the skin or whites of eyes, arising from
excess of the pigment bilirubin and typically caused by obstruction of the bile duct by
liver disease or by excessive breakdown of red blood cells.
2. Bitterness, resentment or cynicism.
3. It is also called icterus yellowing of the skin and white of the eyes due to the
abnormal  presence of bile pigments in the blood as in  hepatitis.
Causes
Jaundice may be caused by several different disease processes. It is helpful to
understand the different causes of jaundice by identifying the problems that disturb the
normal bilirubin metabolism and or excretion.
Signs and Symptoms
Already mentioned  Jaundice is not a disease but rather a visible sign of an
underlying disease process.
Individuals with jaundice will have a yellow discoloration of the skin or varying
degree and may also exhibit yellowing of the mucous membranes and the white of eyes.
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Pale coloured - stools
Dark coloured - urine
Skin - itching
Nausea and vomiting , Rectal bleeding, Diarrhoea, Fever and chills, Weakness,
weight loss, loss of appetite, confusion, abdominal pain headache  swelling of the legs and
swelling and  distension of  the abdomen.
Types of Jaundice
There are three main types of jaundice
Hepatocellular jaundice:
Yellowness of skin,  sclera,  mucous membranes and excret ion due to
hyperbilirubinemia  and deposition of bile pigments.It is usually first noticeable in the
eyes, although it may  come on so gradually that is not immediately noticed by those in
daily contact with the jaundiced person called also icterus.
Jaundice is not a disease;it is a symptom of a number of different diseases and
disorders of the liver and gallbladder and of hemolytic blood disorders.One such disorder
is the presence of a gallstone in the common bile duct, which carries bile from the liver to
the intestine. This may obstruct the flow of bile, causing it to accumulate and enter the
bloodstream. The obstruction of bile flow may cause bile to enter the urine, making it dark
in colour, and also decrease the bile in the stool, making it light and clay-coloured. This
condition requires surgery to remove the gallstone before it causes serious liver injury.
Obstructive jaundice:
Obstructive Jaundice is a particular type of jaundice and occurs when the essential
flow of bile to the intestine is blocked and remains in the bloodstream. This might be due
to blocked bile ducts caused by gall stones or tumours of the bile duct which can block the
area where the bile duct meets the duodenum. These may be cancerous. Other conditions
that can cause obstructive jaundice include those that cause pressure on the bile duct such
as swelling of lymph glands scar tissue (from previous infections or surgery),or a cyst,
possibly of the pancreas.
PRECLINICAL STUDY OF PAVALAVEERA CHUNNAM 59
Hemolytic  jaundice:
A type of jaundice that occurs as a result of hemolysis (an accelerated breakdown
of erythrocytes- red blood cells) leading to an increase in production of  bilirubin
Gall stone Formation
1 Gall stones are pieces of solid material that form in the gall bladder. These stones
develop because cholesterol and pigments in bile.
2 Gall stones can form when there is an imbalance in the substance that make up bile
for instance, cholesterolstones may develop as result of too much cholesterol in the bile.
3 Another cause may be the inability of the gallbladder to empty properly.
Although anyone can develop gallstones older and overweight people are more
likely to get them further more women are at greater risk of developing gallstones.
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4.MATERIALS AND METHODS
4.1 PREPARATION OF THE DRUG:
Selection of drug:
      The Drug “Pavalaveerachunnam” has been selected for Hepatoprotective,
Hypolipidemic, Diuretic and Lithotriptic activitities from the Classical Siddha literature
“The pharmacopoeia of siddha research medicines “ authored by Shanmugavelu.M.Dr.,
Page no: 86.
Ingredients of the drug:
1. Veeram (Terlinguiate-Hg2clo)
2. Pavalam (Coral)- (Corallum rubrum.)
3. Goat bile
Collection of the drugs:
The raw material of Veeram was bought from the raw country drug shop at
Nagercovil  Kanniyakumari District, Tamilnadu.
          The material Coral was bought from the raw country drug shop at Coimbathur,
Kovai District, Tamilnadu.
Goat bile were  collected  from slater house, Tirunelveli market, Tamilnadu.
Identification and authentication:
All raw drugs were identified and Authenticated by the experts of Geology
department  in V.O.Chidambaram college Toothukudi, Tirunelveli District.
The specimen samples of the identified raw drugs were preserved in the laboratory of PG
Gunapadam department in Govt.SiddhaMedical College,Palayamkottai for future
references.
Purification of raw drugs:
Veeram - Tender coconut water and sufficient quantity of camphor mixed and poured into
a pot. Veeram is packed with cotton cloth (Thulaenthiram) and suspended above the water
level. It boiled for half an hour or until the water level reduced by 13 . The veeram washed
out thoroughly and dried.
Pavalam -  Pavalam is soaked in lemon juice for one day(24hrs).The next day   it is
washed with hot water and dried.
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Preparation of Pavalaveerachunnam:
Ingredients of the drug ,
1. Veeram                         - 10gms (1part).
2. Pavalam (Coral)          - 100gms (10part).
3. Goat Bile                    - Sufficient
Process:
Purified Pavalam and Veeram are broken into small pieces are powdered coarsely.
Then put into mudpot (Kuduvai) and poured goat bile and stirred well and kept for a day.
Next day exposed to the sunlight for drying.
Trituration:  The above material was powdered well. Then it was triturated with Goatbile
Villai(small cakes) preparation and sealing:
The mixture was made into small cakes (coin size). Then it dried under sunlight
for two days. Then it placed in an earthen crucible and it is covered by internal earthen
crucible. The margins are tightly sealed with a mud pasted cloth seven times and then it
dried under sunlight for one day.
Incineration and trituration:
Then the earthen crucible was subjected to pudam (incineration) process with 250
cow dung cakes. After finishing pudam process let the earthen crucible undisturbed to
give away heat. The seal was opened on the next day. The cakes of Pavalaveeram was
collected and ground well. Finally Chunnam is obtained. The colour of the Cunnam is
white in colour and the consistency was very fine.
Storage:
The drug Pavalaveera chunnam was stored in a clean air tight glass container and
used for further studies.
Administration of the drug:
Form of the drug    :   Powder (Chunnam)
Route                      :   Enteral(oral)
Dose                       :   65-130-mg (1-2 grains)
Adjuvant                 :   Suitable adjuvant
Shelf life                 :   500 years.
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4.2. STANDARDIZATION OF THE DRUG
4.2.1. AS PER SIDDHA CLASSICAL LITERATURE:
         Standardization of drug means confirmation of it’s quality and purity and detection
of the nature of adulterant of various parameters like morphological, microscopic, physical,
chemical and biological observations.
1. Colour:
The finished form of Chunnam is white in colour.
2. Odour:
The finished form of Chunnam is odourless, without any odour related to it’s
ingredients.
3. Taste:
A small amount of Chunnam was kept in the tip of the tongue, which is
tasteless.Properly prepared  Chunnam should be completely tasteless. If any taste present
in Chunnam, it indicates the preparation was not well prepared. It needs another
pudam(incineration) process.
4. Finger Print Test:
Well prepared Chunnamshould be very fine. A pinch of Chunnamwas taken and
rubbed in between the thumb and index finger. It entered into the depressions and furrows
of the fingers. Itconfirmes the fineness of Chunnam.
5. Floating on Water:
A pinch of Chunnamwas sprinkled over the water in a glass container. The
Chunnamparticles did not sink but floated on the water surface. It indicates the lightness
of Chunnam.
6. Lustre:
If any glowing particles seen in the Chunnam, it shows that the drug is not prepared
properly and possess unchanged substances like metals and other toxic substances. So, there
should be no glowing particles present in the properly prepared Chunnam. The Chunnam
was taken in a Petri dish and observed for any lustre in daylight via magnifying glass.
7.Colour change
The chunnam was mixed with termaric powder. The yellow colour was changed
into red colour
PRECLINICAL STUDY OF PAVALAVEERA CHUNNAM 63
4.2.2. STANDARDIZATION OF TEST DRUG BY USING MODERN
TECHNIQUES:
Standardization of drug helps to authenticate and determine its quality and
efficiency. Thus, the process involves qualitative and quantitative analysis by means of
physico – chemical properties and instrumental analysis.
The physic-chemical analysis of Pavalaveerachunnam has been done in Aravind
Herbal Labs (P) Ltd., Rajapalayam.
The chemical finger prints are engaged by using modern analytical technique Fourier
Transform Infra –Red Spectroscopy (FTIR) and Inductively coupled plasma mass
spectrometry( ICP-MS)
The particle size and qualitat ive analysis of  chemical elements of
pavalaveerachunnam assessed by Scanning Electron Microscope (SEM) and Inductively
Coupled Plasma Optical Emission Spectroscopy (ICP-OES) and Inductively coupled
plasma(ICP-MS)
4.2.2.1 PHYSICO CHEMICAL ANALYSIS:
Solubility test:
A. A little amount of the sample was taken in a dry test tube and shaken well with
distilled water.
B. A little amount of the sample was taken in a clean dry test tube and then shaken
well with con.HCl and Con.H2SO4. Sparingly soluble character of the sample indicates
the presence of Silicate.
Action on heat:
A small amount of the sample was taken in a clean dry test tube and heated gently.
If strong white fumes evolve indicate the presence of Carbonate.
Flame test:
A small amount of the sample was taken in a clean dry watch glass. It was
made into paste with concentrated HCL. And then it was introduced into non-luminous
part of the Bunsen flame. If bluish green flame appears, it indicates the presence of
copper.
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Ash test:
A small amount of sample was mixed with the cobalt nitrate solution. A filter
paper was soaked into the mixture. Then it was introduced into the Bunsen flame and
ignited. If yellow colour flame appears, it reveals the presence of sodium.
Determination of Total Ash:
Incinerate about 2 to 3 g accurately weighed, of the ground drug in a tared platinum
or silica dish at a temperature not exceeding 450º until free from carbon, cool and weigh.
If a carbon free ash cannot be obtained in this way, exhaust the charred mass with hot
water, collect the residue on an ashless filter paper, incinerate the residue and filter paper,
add the filtrate, evaporate to dryness, and ignite at a temperature not exceeding 450º.
Calculate the percentage of ash with reference to the air-dried drug.
Determination of Acid Insoluble Ash:
Boil the ash obtained in above test for 5 minutes with 25 ml of dilute hydrochloric
acid; collect the insoluble matter in a Gooch crucible, or on an ashlessfilter paper, wash
with hot water and ignite to constant weight. Calculate the percentage of acid-insoluble
ash with reference to the air dried drug.
Determination of Moisture Content (Loss on Drying):
Procedure set forth here determines the amount of volatile matter (i.e., water drying
off from the drug). For substances appearing to contain water as the only volatile constituent,
the procedure given below, is appropriately used.
Place about 10 g of drug (without preliminary drying) after accurately weighing
(accurately weighed to within 0.01 g) it in a tared evaporating dish. For example, for
underground or unpowdered drug, prepare about 10 g of the sample by cutting shredding
so that the parts are about 3 mm in thickness.
Seeds and fruits, smaller than 3 mm should be cracked. Avoid the use of high
speed mills in preparing the samples, and exercise care that no appreciable amount of
moisture is lost during preparation and that the portion taken is representative of the official
sample. After placing the above said amount of the drug in the tared evaporating dish dry
at 105º for 5 hours, and weigh. Continue the drying and weighing at one hour interval until
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difference between two successive weighings corresponds to not more than 0.25 per cent.
Constant weight is reached when two consecutive weighings after drying for 30 minutes
and cooling for 30 minutes in a desiccator, show not more than 0.01 g difference.
MICROBIAL LIMIT TESTS:
Determination of Total Aerobic Microbial Count:
Dissolve 10 g or dilute 10 ml of the preparation being examined, unless otherwise
specified, in buffered sodium chloride-peptone solution Ph 7.0 or any other suitable medium
shown to have no antimicrobial activity under the conditions of test and adjust the volume
to 100 ml with the same medium. If necessary, adjust the pH to about 7.
Membrane filtration:
 Use membrane filters 50 mm in diameter and having a nominal pore size not
greater than 0.45 μm the effectiveness of which in retaining bacteria has been established
for the type of preparation being examined. Sterilise and assemble the filtration apparatus
described under tests for sterility.
Transfer 10 ml or a quantity of each dilution containing 1 g of the preparation
being examined to each of two membrane filters and filter immediately. If necessary, dilute
the pretreated preparation so that a colony count of 10 to 100 may be expected. Wash each
membrane by filtering through it three or more successive quantities, each of about 100
ml, of a suitable liquid such as buffered sodium chloride-peptone solution pH 7.0. For
fatty substances add to the liquid polysorbate 20 or polysorbate 80. Transfer one of the
membrane filters, intended for the enumeration of bacteria, to the surface of a plate of
casein soyabean digest agar and the other, intended for the enumeration of fungi, to the
surface of a plate of Sabouraud dextrose agar with antibiotics.
Incubate the plates for 5 days, unless a more reliable count is obtained in shorter
time, at 30º to 35º in the test for bacteria and 20º to 25º in the test for fungi. Count the
number of colonies that are formed. Calculate the number of micro-organisms per gm or
per ml of the preparation being examined, if necessary counting bacteria and fungi
separately.
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Plate count: For bacteria:
Using Petri dishes 9 to 10 cm in diameter, add to each dish a mixture of 1 ml of the
pretreated preparation and about 15 ml of liquefied casein soyabean digest agar at not
more than 45º. Alternatively, spread the pretreated preparation on the surface of the solidified
medium in a Petri dish of the same diameter. If necessary, dilute the pretreated preparation
as described above so that a colony count of not more than 300 may be expected. Prepare
at least two such Petri dishes using the same dilution and incubate at 30º to 35º for 5 days,
unless a more reliable count is obtained in a shorter time. Count the number of colonies
that are formed. Calculate the results using plates with the greatest number of colonies but
taking 300 colonies per plate as the maximum consistent with good evaluation.
For fungi:
Proceed as described in the test for bacteria but use Sabouraud dextrose agar with
antibiotics in place of casein soyabean digest agar and incubate the plates at 20º to 25º for
5 days, unless a more reliable count is obtained in a shorter time. Calculate the results
using plates with not more than 100 colonies.
TESTS FOR SPECIFIED MICRO-ORGANISMS:
Pretreatment of the sample being examined – Proceed as described under the test
for total aerobic microbial count but using lactose broth or any other suitable medium
shown to have no antimicrobial activity under the conditions of test in place of buffered
sodium chloride-peptone solution pH 7.0.
Escherichia coli:
Place the prescribed quantity in a sterile screw-capped container, add 50 ml of
nutrient broth, shake, allow to stand for 1 hour (4 hours for gelatin) and shake again.
Loosen the cap and incubate at 37º for 18 to 24 hours.
Primary test:
Add 1.0 ml of the enrichment culture to a tube containing 5 ml of MacConkey
broth. Incubate in a water-bath at 36º to 38º for 48 hours. If the contents of the tube show
acid and gas carry out the secondary test.
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Secondary test:
Add 0.1 ml of the contents of the tubes containing (a) 5 ml of MacConkey broth,
and (b) 5 ml of peptone water. Incubate in a water-bath at 43.5º to 44.5º for 24 hours and
examine tube (a) for acid and gas and tube (b) for indole. To test for indole, add 0.5 ml of
Kovac’s reagent, shake well and allow to stand for 1 minute; if a red colour is produced in
the reagent layer indole is present. The presence of acid and gas and of indole in the
secondary test indicates the presence of Escherichia coli.
Carry out a control test by repeating the primary and secondary tests adding 1.0 ml
of the enrichment culture and a volume of broth containing 10 to 50 Escherichia coli
(NCTC 9002) organisms, prepared from a 24-hour culture in nutrient broth, to 5 ml of
MacConkey broth. The test is not valid unless the results indicate that the control contains
Escherichia coli.
Salmonella:
Transfer a quantity of the pretreated preparation being examined containing 1 gm
or 1 ml of the product to 100 ml of nutrient broth in a sterile screwcapped jar, shake, allow
to stand for 4 hours and shake again. Loosen the cap and incubate at 35º to 37º for 24
hours.
Primary test:
Add 1.0 ml of the enrichment culture to each of the two tubes containing (a) 10 ml
of selenite F broth and (b) tetrathionate-bile-brilliant green broth and incubate at 36º to
38º for 48 hours. From each of these two cultures subculture on at least two of the following
four agar media: bismuth sulphate agar, brilliant green agar, desoxycholatecitrate agar and
xylose-lysine-desoxycholate agar. Incubate the plates at 36º to 38º for 18 to 24 hours.
Upon examination, if none of the colonies conforms to the description given in Table 2,
the sample meets the requirements of the test for the absence of the genus Salmonella.
If any colonies conforming to the description in Table 3 are produced, carry out the
secondary test.
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Secondary test:
Subculture any colonies showing the characteristics given in Table 3 in triple sugar-
iron agar by first inoculating the surface of the slope and then making a stab culture with
the same inoculating needle, and at the same time inoculate a tube of urea broth. Incubate
at 36º to 38º for 18 to 24 hours. The formation of acid and gas in the stab culture (with or
without concomitant blackening) and the absence of acidity from the surface growth in
the triple sugar iron agar, together with the absence of a red colour in the urea broth,
indicate the presence of salmonellae. If acid but no gas is produced in the sub culture, the
identity of the organisms should be confirmed by agglutination tests.
Carry out the control test by repeating the primary and secondary tests using 1.0 ml of the
enrichment culture and a volume of broth containing 10 to 50 Salmonella abony (NCTC
6017) organisms, prepared from a 24-hour culture in nutrient broth, for the inoculation of
the tubes (a) and (b). The test is not valid unless the results indicate that the control contains
Salmonella.
Table No. 1.Tests for Salmonella
Medium Description of colony
Bismuth Sulphite agar Black or green
Brilliant green agar Small, transparent and colorless, or opaque, pinkish
or white (frequently surrounded by a pink or red
zone)
Deoxycholate – Citrate agar Colourless and opaque, with or without black
centers
Xylose-lysine-desoxy-cholate agar Red with or without black centers
Pseudomonas aeruginosa:
 Pretreat the preparation being examined as described above and inoculate 100 ml
of fluid soyabean-casein digest medium with a quantity of the solution, suspension or
emulsion thus obtained containing 1 g or 1 ml of the preparation being examined. Mix and
incubate at 35º to 37º for 24 to 48 hours. Examine the medium for growth and if growth is
present, streak a portion of the medium onthe surface of cetrimide agar medium, each
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plated on Petri dishes. Cover and incubate at 35º to 37º for 18 to 24 hours. If, upon
examination, none of the plates contains colonies having the characteristics listed in Table
4 for the media used, the sample meets the requirement for freedom from Pseudomonas
aeruginosa. If any colonies conforming to the description in Table 4 are produced, carry
out the oxidase and pigment tests.
Streak representative suspect colonies from the agar surface of cetrimide agar on
the surfaces of pseudomonas agar medium for detection of fluorescein and pseudomonas
agar medium for detection of pyocyanin contained in Petri dishes. Cover and invert the
inoculated media and incubate at 33º to 37º for not less than 3 days. Examine the streaked
surfaces under ultra-violet light. Examine the plates to determine whether colonies
conforming to the description in Table 4 are present.
If growth of suspect colonies occurs, place 2 or 3 drops of a freshly prepared 1%
w/v solution of N, N, N1, N1-tetramethyl-4-phenylenediamine dihydrochloride on filter
paper and smear with the colony; if there is no development of a pink  colour, changing to
purple, the sample meets the requirements of the test for the absence of Pseudomonas
aeruginosa.
Table No. 2. Tests for Pseudomonas aeruginosa
Medium Characteristic 
colonical 
morphology 
Fluorescence 
in UV light  
Oxidase test Gram stain 
Cetrimde agar Generally greenish Greenish Positive Negative rods 
Pseudomonas 
agar medium 
for detection 
of fluorescein 
Generally colourless 
to yellowish 
Yellowish Positive Negative rods 
Pseudomonas 
agar medium 
for detection 
of pyocyanin 
Generally greenish Blue  Positive Negative rods 
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Staphylococcus aureus:
Proceed as described under Pseudomonas aeruginosa. If, upon examination of the
incubated plates, none of them contains colonies having the characteristics listed in Table
5 for the media used, the sample meets the requirements for the absence of Staphylococcus
aureus.
If growth occurs, carry out the coagulase test. Transfer representative suspect
colonies from the agar surface of any of the media listed in Table 5 to individual tubes,
each containing 0.5 ml of mammalian, preferably rabbit or horse, plasma with or without
additives. Incubate in water-bath at 37º examining the tubes at 3 hours and subsequently
at suitable intervals up to 24 hours. If no coagulation in any degree is observed, the sample
meets the requirements of the test for the absence of Staphylococcus aureus.
Table No. 3.Tests for Staphylococcus aureus
Selective medium Characteristic colonical morphology Gram stain 
Vogel-Johnson agar Black surrounded by yellow zones` Positive cocci (in clusters) 
Mannitol-salt agar Yellow colonies with yellow zones Positive cocci (in clusters) 
Baired-Parker agar Black, shiny, surrounded by clear zones 
of 2 to 5 mm 
Positive cocci (in clusters) 
 
Thin-Layer Chromatography (TLC)
Thin-layer chromatography is a technique in which a solute undergoes distribution
between two phases, stationary phase acting through adsorption and a mobile phase in the
form of a liquid. The adsorbent is a relatively thin, uniform layer of dry finely powdered
material applied to a glass, plastic or metal sheet or plate. Glass plates are most commonly
used. Separation may also be achieved on the basis of partition or a combination of partition
and adsorption, depending on the particular type of support, its preparation and its use
with different solvent.
Identification can be effected by observation of spots of identical Rf value and
about equal magnitude obtained, respectively, with an unknown and a reference sample
chromatographed on the same plate. A visual comparison of the size and intensity of the
spots usually serves for semi-quantitative estimation.
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Apparatus
a) Flat glass plates of appropriate dimensions which allow the application at specified
points of the necessary quantities of the solution being examined and appropriate
reference solutions and which allow accommodation of the specified migration
path-length. The plates are prepared as described below; alternatively, commercially
prepared plates may be used.
b) An aligning tray or a flat surface on which the plates can be aligned and rested
when the coating substance is applied.
c) The adsorbent or coating substance consisting of finely divided adsorbent materials,
normally 5ìm to 40ìm in diameter is suitable for chromatography. It can be applied
directly to the plate or can be bonded to the plate by means of Plaster of Paris
(Hydrated Calcium Sulphate) or with any other suitable binders. The adsorbent
may contain fluorescing material to help in visualizing spots that absorb ultra-
violet light.
d) A spreader which, when moved over the glass plate, will apply a uniform layer of
adsorbent of desired thickness over the entire surface of the plate.
e) A storage rack to support the plates during drying and transportation.
f) A developing chamber that can accommodate one or more plates and can be properly
closed and sealed. The chamber is fitted with a plate support rack that supports the
plates, back to back, with lid of the chamber in place.
g) Graduated micro-pipettes capable of delivering microlitre quantities say 10ìl and
less.
h) A reagent sprayer that will emit a fine spray and will not itself be attacked by the
reagent.
i) An ultra-violet light, suitable for observation at short (254 nm) and long (365 nm)
ultra-violet wavelengths.
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Preparation of plates:
Unless otherwise specified in the monograph, the plates are prepared in the following
manner. Prepare a suspension of the coating substance in accordance with the instructions
of the supplier and, using the spreading device designed for the purpose, spread a uniform
layer of the suspension, 0.25 to 0.30 mm thick, on a flat glass plate 20 cm long. Allow the
coated plates to dry in air, heat at 100º to 105º for at least 1 hour (except in the case of
plates prepared with cellulose when heating for 10 minutes is normally sufficient) and
allow to cool, protected from moisture. Store the plates protected from moisture and use
within 3 days of preparation. At the time of use, dry the plates again, if necessary, as
prescribed in the monographs.
Method
Unless unsaturated conditions are prescribed, prepare the tank by lining the walls
with sheets of filter paper; pour into the tank, saturating the filter paper in the process,
sufficient of the mobile phase to form a layer of solvent 5 to 10 mm deep, close the tank
and allow to stand for 1 hour at room temperature. Remove a narrow strip of the coating
substance, about 5 mm wide, from the vertical sides of the plate. Apply the solutions being
examined in the form of circular spots about 2 to 6 mm in diameter, or in the form of bands
(10 to 20 mm x 2 to 6 mm unless otherwise specified) on a line parallel with, and 20 mm
from, one end of the plate, and not nearer than 20 mm to the sides; the spots should be 15
mm apart. If necessary, the solutions may be applied in portions, drying between
applications. Mark the sides of the plate 15 cm, or the distance specified in the monograph,
from the starting line. Allow the solvent to evaporate and place the plate in the tank,
ensuring that it is as nearly vertical as possible and that the spots or bands are above the
level of the mobile phase. Close the tank and allow to stand at room temperature, until the
mobile phase has ascended to the marked line. Remove the plate and dry and visualise as
directed in the monograph; where a spraying technique is prescribed it is essential that the
reagent be evenly applied as a fine spray.
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For two-dimensional chromatography dry the plate after the first development and
carry out the second development in a direction perpendicular to the first.
When the method prescribed in the monograph specified ‘protected from light’ or
‘in subdued light’ it is intended that the entire procedure is carried out under these conditions.
Visualisation
The phrases ultra-violet light (254 nm) and ultra-violet light (365 nm) indicate that
the plate should be examined under an ultra-violet light having a maximum output at
about 254 or at about 365 nm, as the case may be.
The term secondary spot means any spot other than the principal spot. Similarly, a
secondary band is any band other than the principal band.
Rf. Value
Measure and record the distance of each spot from the point of its application and
calculate the Rf. value by dividing the distance travelled by the spots by the distance
travelled by the front of the mobile phase.
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4.2.2.2 CHEMICAL ANALYSIS:
Preliminary Basic and Acidic Radical Studies:
Preparation of the Extract:
100mg of TPP is weighed accurately and placed into a clean beaker and added a
few drops of conc. Hydrochloric acid and evaporated it well. After evaporation cooled the
content and added a few drops of conc. Nitric acid and evaporated it well. After cooling
the content add 20ml of distilled water and dissolved it well. Then it is transferred to
100ml with distilled water and stirred well. Filter it. Then it is taken for analysis.
Qualitative Analysis For Basic Radicals:
Test for Calcium:
2ml of the above prepared extract is taken in a clean test tube. To this add 2ml of
4% Ammonium oxalate solution. Formation of white precipitate indicates the presence of
calcium.
Test for Iron (Ferric):
The extract is acidified with glacial acetic acid and potassium ferro cyanide.
Formation of blue colour indicates the presence of ferric iron.
Test for Iron (Ferrous):
The extract is treated with concentrated Nitric acid and ammonium thio-cyanate
solution. Formation of blood red colour indicates the presence of ferrous iron.
Test for Zinc:
The extract is treated with potassium ferro-cyanide. Formation of white precipitate
indicates the presence of zinc.
Qualitative Analysis for Acidic Radicals:
Test for Sulphate:
2ml of extract is added to 5% barium chloride solution. Formation of white
precipitate indicates the presence of sulphate.
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Test for Chloride:
The extract is treated with silver nitrate solution. Formation of white precipitate
indicates the presence of chloride.
Test for Phosphate:
The extract is treated with ammonium molybdate and concentrated nitric acid.
Formation of yellow precipitate indicates the presence of phosphate.
Test for Carbonate:
On treating the extract with concentrated hydrochloric acid giving brisk
effervescence indicates the presence of carbonate.
Test for starch:
The extract is added with weak iodine solution. Formation of blue colour indicates
the presence of starch.
Test for albumin:
The extract is treated with Esbach‘s reagent. Formation of yellow precipitate
indicates the presence of albumin.
Test for tannic acid:
The extract is treated with ferric chloride. Formation of bluish black precipitate
indicates the presence of tannic acid.
Test for unsaturation:
The extract is treated with potassium permanganate solution. The dis-colourization
of potassium permanganate indicates the presence of unsaturated compounds.
Test for the reducing sugar:
5ml of Benedict‘s qualitative solution is taken in a test tube and allowed to boil for
2 minutes and added 8-10 drops of the extract and again boil it for 2 minutes. Any colour
change indicates the presence of reducing sugar.
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Test for aminoacid:
One or two drops of the extract is placed on a filter paper and dried it well. After
drying, 1% Ninhydrin is sprayed over the same and dried it well. Formation of violet
colour indicates the presence of amino acid.
Test for mercury:
        The extract is heated with Ammonia and boil (still the ammonia caeses off) and then
potassium iodide (1% solution) is added .No scarlet precipitate is formed.It indicates the
absence of mercury.
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4.2.2.3 INSTRUMENTAL ANALYSIS
SCANNING ELECTRON MICROSCOPE (SEM)
Figure No 4: HITACHI S-3400H SEM ANALYSER
The microstructure of the powders was examined using a Hitachi S 3000H scanning
electron microscope (Fig.12). The scanning Electron Microscope is one of the most versatile
instruments available for the examination and analysis of the micro structural characteristics
of solid objects. The primary reason for the SEM’s usefulness is the high resolution which
can be obtained when bulk objects are examined; values of the order of 5nm (50degreeA)
are usually quoted for commercial instruments. Advanced research instruments have been
described which have achieved resolutions of about 2.5nm (25 degree A). Any solid material
can be studied. Sample size is limited to specimens less than about 10μm in diameter. An
electron beam passing through an evacuated column is focused by electromagnetic lenses
onto the specimen surface. The beam is then rastered 0ver the specimen in synchronism
with the beam of a cathode ray tube display screen. In eleastically scattered secondary
electrons are emitted from the sample surface and collected by a scintillator, the signal
from which is used to modulate the brightness of the cathode ray tube. In this way the
secondary electron emission from
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the sample is used to form an image on the CRT display screen. (Goldstein, et. al.,
1992)
Figure No 5: MECHANISM OF SEM ANALYSER
Differences in secondary emission result from changes in surface topography.
If (elastically) back-scattered electrons are collected to form the image, contrast results
from compositional differences. Cameras are provided to record the images on the display
screen. Since an electron is a charged particle, it has a strong interaction with the specimen
(due to coulomb interaction). When an electron beam images on a specimen, it is scattered
by atomic layers near the surface of the specimen. As a result, the direction of electron
motion changes and its energy is partially lost. Once an incident electron (primary
electron)enters a substance, its direction of motion is influenced by various obstructions
(multiple scattering), and follows a complicated trajectory which is far from a straight
line. Also, when electrons with the same energy are incident on the specimen surface, a
portion of electrons is reflected in the opposite direction (back scattered) and the remainder
is absorbed by the specimen (exciting X- rays or other quanta in the process). If the specimen
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is sufficiently thin, the electron can pass all the way through the specimen (transmitted
electrons, scattered or non-scattered).
The depth at which various signals are generated due to electron beam – specimen
interaction indicates the diffusion area of the signals in the specimen in addition to the
local chemistry of the specimen. Secondary electrons mainly indicate information about
the surface of a specimen. Since secondary electrons do not diffuse much inside the
specimen, they are most suitable for observing the fine-structures of the specimen surface.
That is to say, sharp scanning images with high resolution can be expected from secondary
electrons, because of the smaller influence on resolution by their diffusion.
As the incident electron energy increases, the probability of incident electrons
colliding with elemental components of the specimen and releasing secondary electrons
also increases. In other words, as the incident energy increases, the emission of electrons
from the specimen also increases. However, as the energy increases beyond a certain level,
the incident electrons penetrate deeper into the specimen with the result that the specimen
derived electrons use up most of their energy to reach the specimen surface. Consequently,
the electron emission yield decreases. Therefore, the peak secondary electron emission
yield occurs at a specific entry level of the incident electrons.
In order to verify the existence of a substance and recognize its shape, the image contrast
must be well defined. In other words, even if a system boasts extremely high resolution, if
image contrast is poor, it would be extremely difficult to determine the existence of a
substance, let alone recognize its shape. Another important feature of the SEM is the
three-dimensional appearance of the specimen image, which is a direct result of the large
depth of field. The SEM is also capable of examining objects at very low magnification.
This feature is useful in viewing particle size and shape of any composition at various
stages of preparation in siddha system as well as other fields.
The large depth of field available in the SEM makes it possible to observe 3-
dimensional objects in stereo. Today, a majority of SEM facilities are equipped with X-ray
analytical capabilities. Thus topographic crystallographic and compositional information
can be obtained rapidly, efficiently and simultaneously from the same area.
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The author was chosen this analysis for detecting Particle size of the classical siddha
mineral drug Pavalaveerachunnam.SEM results of Pavalaveerachunnamwas represented
in results section.
INDUCTIVELY COUPLED PLASMA - OPTICAL EMISSION
SPECTROMETRY  (ICP-OES)
Figure No 6: IMAGE OF ICP-OES
Inductively coupled plasma optical emission spectrometry (ICP-OES) is an
analytical technique used for the detection of trace metals. It is a type of emission
spectroscopy that uses the inductively coupled plasma to produce excited atoms and ions
that emit electromagnetic radiation at wavelengths characteristic of a particular element.
The intensity of this emission is indicative of the concentration of the element within the
sample.
Mechanism
The ICP-OES is composed of two parts: the ICP and the optical spectrometer. The
ICP torch consists of 3 concentric quartz glass tubes. The output or “work” coil of the
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radiofrequency (RF) generator surrounds part of this quartz torch. Argon gas is typically
used to create the plasma.
When the torch is turned on, an intense electromagnetic field is created within the
coil by the high power radio frequency signal flowing in the coil. This RF signal is created
by the RF generator which is, effectively, a high power radio transmitter driving the
“workcoil” the same way a typical radio transmitter drives a transmitting antenna. The
argon gas flowing through the torch is ignited with a Tesla unit that creates a brief discharge
arc through theargon flow to initiate the ionization process. Once the plasma is “ignited”,
the Tesla unit is turned off.
The argon gas is ionized in the intense electromagnetic field and flows in a particular
rotationally symmetrical pattern towards the magnetic field of the RF coil. A stable, high
temperature plasma of about 7000 K is then generated as the result of the inelastic collisions
created between the neutral argon atoms and the charged particles. A peristaltic pump
delivers an aqueous or organic sample into a nebulizer where it is changed into mist and
introduced directly inside the plasma flame. The sample immediately collides with the
electrons and charged ions in the plasma and is itself broken down into charged ions. The
various molecules break up into their respective atoms which then lose electrons and
recombine repeatedly in the plasma, giving off radiation at the characteristic wavelengths
of the elements involved.
Within the optical chamber(s), after the light is separated into its different
wavelengths (colors), the light intensity is measured with a photomultiplier tube or tubes
physically positioned to “view” the specific wavelength(s) for each element line involved
, or, in more modern units, the separated colors fall upon an array of semiconductor photo
detectors such as charge coupled devices (CCDs). In units using these detector arrays, the
intensities of all wavelengths (within the system’s range) can be measured simultaneously
,allowing the instrument to analyze for every element to which the unit is sensitive all at
once. Thus, samples can be analyzed very quickly.
The intensity of each line is then compared to previously measured intensities
ofknown concentrations of the elements, and their concentrations are then computed by
interpolation along the calibration lines. In addition, special software generally corrects
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for interferences caused by the presence of different elements within a given sample matrix.
Examples of the application of ICP-OES include the determination of metals, arsenic
present in Traditional medicines, and trace elements bound to proteins. ICP-OES is widely
used in minerals processing to provide the data on grades of various streams, for the
construction of mass balances.
The author used for elemental identification and quantitative compositional
information of the   Pavalaveerachunnam
FOURIER TRANSFORM - INFRA RED SPECTROSCOPY (FT-IR)
Figure No 7: FTIR-SPECTRUM ANALYSER
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Figure No 8: MECHANISM OF FTIR SAMPLING TECHNIQUES
Introduction
Vibrational spectroscopy is an extremely useful tool in the elucidations of molecular
structure. The spectral bands can be assigned to different vibrational modes of the molecule.
The various functional groups present in the molecule can be assigned by a comparison of
the spectra with characteristic functional group frequencies. As the positions of the bands
are directly related to the strength of the chemical bond, a large number of investigations
including intermolecular interactions, phase transitions and chemical kinetics can be carried
out using this branch of spectroscopy. In IR spectroscopy, the resonance absorption is
made possible by the change in dipole moment accompanying the vibrational transition.
The Infrared spectrum originates from the vibrational motion of the molecule. The
vibrational frequencies are a kind of fingerprint of the compounds. This property is used
for characterization of organic, inorganic and biological compounds. The band intensities
are proportional to the concentration of the compound and hence qualitative estimations
are possible. The IR spectroscopy is carried out by using Fourier transform technique.
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Principle
Infra red spectroscopy involves study of the interaction of electromagnetic radiation
with matter. Due to this interaction, electromagnetic radiation characteristic of the
interacting system may be absorbed (or emitted). The experimental data consist of the
nature (frequency of wave length) and the amount (intensity) of the characteristic radiation
absorbed or emitted. These data are correlated with the molecular and electronic structure
of the substance and with intra- and inter molecular interactions.
Source : Nernst Glower
Beam splitter : It is made up of a transparent material. Thin films
ofSilicondeposited on Potassium bromide (KBr)
Bromide (KBr) Detectors : DeutratedTriGlycineSulphate (DTGS).
MIR Range : 4000 to 450 cm-1
Resolution : 4.0 cm-1
Sampling Techniques
There are a variety of techniques for sample preparation depending on the physical
form of the sample to be analyzed.
Solid : KBr or Nujol mull method.
Liquid : Csl / TIBr Cells
Gas : Gas cells
KBr Method
 The sample is grounded using an agate mortar and pestle to give a very fine powder.
 The finely powder sample is then mixed with about 100mg dried KBr salt.
 The mixture is then pressed under hydraulic press using a die to yield a transparent
disc and measure about 13mm diameter and 0.3mm in thickness.
Nujol Mull Method
 The sample is ground using an agate mortar and pestle to give a very fine
powder.
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 A small amount is then mixed with nujol oil to give a paste and this paste is
then applied between two sodium chloride plates.
 The plates are then placed in the instrument sample holder ready for scanning.
Liquids
 Viscous liquids can be smeared in the cell and directly measured.
 For dilute solutions, liquid cells and variable path length cells are employed.
Measurements Techniques
The procedure for recording the %T or %A is as follows:
 Air is first scanned for the reference and stored. The sample is then recorded and
finally the ratio of the sample and reference data is computed to give required %T
or %A at various frequencies.
 Study of substances with strong absorbance bands and weak absorbance bands
aswell as possible.
 Small amount of samples are sufficient
 High resolution is obtained.
Procedure
 Preparation of samples for infrared measurements and infrared spectra Typically,1.5
mg of protein, dissolved in the buffer used for its purification, were centrifuged in
a 30 K Centric on micro concentrator (Amicon) at 3000_g at 4oC until a volume of
approximately 40 Al.
 Then, 300 Al of 20 mMThis buffer, prepared in H20 or 2H20, pH or p2H 7.2, were
added and the sample concentrated again. The p2H value corresponds to the pH
meter reading + 0.4. The concentration and dilution procedure was repeated several
times in order to completely replace the original buffer with the Tris buffer.
 The washings took 24 h, which is the time of contact of the protein with the 2H20
medium prior FT-IR analysis. In the last washing, the protein was concentrated to
fine a volume of approximately 40 Al and used for the infrared measurements.
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 The concentrated protein sample was placed in CaF2 windows and a 6 Am tin
spacer or a 25 Am Teflon spacer for the experiments in H20 or 2H20, respectively.
FT-IR spectra were recorded by means of a Perkin-Elmer -Spectrum-1 FT-IR
spectrometer using a deuteratedtriglycinesulfate detector.
 At least 24 h before, and during data acquisition, the spectrometer was continuously
purged with dry air at a dew point of 40oC. Spectra of buffers and samples were
acquired at 2 cm_1 resolution under the same scanning and temperature conditions.
In the thermal denaturation experiments, the temperature was raised in 5oC steps
from 20 to 95 oC.
 Before spectrum acquisition, samples were maintained at the desired temperature
for the time necessary for the stabilization of temperature inside the cell (6 min).
 Spectra were collected and processed using the SPECTRUM software from Perkin-
Elmer. Correct subtraction of H20 was judged to yield an approximately flat baseline
at 1900-1400 cm_ 1, and subtraction of 2H20 was adjusted to the removal of
the2H20 bending absorption close to 1220 cm_ 1
 Pavalaveerachunnamis a mineral combination drug. FT-IR study was selected to
identify the inorganic material of the test drug.The results are tabulated for further
discussion.
PRECLINICAL STUDY OF PAVALAVEERA CHUNNAM 87
INDUCTIVELY COUPLED PLASMA OPTICAL MASS
SPECTROMETRY (ICP-MS)
Figure No :9 IMAGE OF ICP -MS
Inductively coupled plasma mass spectrometry (ICP-MS) is a type of mass
spectrometry which is capable of detecting metals and several non­metals at concentrations
as low as one part in 1015 (part per quadrillion, ppq) on non­interfered low­background
isotopes. This is achieved by ionizing the sample with inductively coupled plasma and
then using a mass spectrometer to separate and quantify those ions.
Compared to atomic absorption techniques, ICP-MS has greater speed, precision,
and sensitivity. However, compared with other types of mass spectrometry, such as Thermal
ionization mass spectrometry (TIMS) and Glow Discharge Mass Spectrometry (GD-MS),
ICP-MS introduces many interfering species: argon from the plasma, component gases of
air that leak through the cone orifices, and contamination from glassware and the cones.
The variety of applications exceeds that of inductively coupled plasma atomic emission
spectroscopy and includes isotopic speciation. Due to possible applications in nuclear
technologies, ICP-MS hardware is a subject for special exporting regulations.
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Inductively coupled plasma
An inductively coupled plasma is a plasma that is energized (ionized) by inductively
heating the gas with an electromagnetic coil, and contains a sufficient concentration
of ions and electrons to make the gas electrically conductive. Even a partially ionized gas
in which as little as 1% of the particles are ionized can have the characteristics of a plasma
(i.e., response to magnetic fields and high electrical conductivity).The plasmas used in
spectrochemical analysis are essentially electrically neutral, with each positive charge on
an ion balanced by a free electron. In these plasmas the positive ions are almost all singly
charged and there are few negative ions, so there are nearly equal amounts of ions and
electrons in each unit volume of plasma.
An  inductively coupled plasma (ICP) for spectrometry is sustained in a torch that
consists of three concentric tubes, usually made of quartz, although the inner tube (injector)
can be sapphire if hydrofluoric acid is being used. The end of this torch is placed inside an
induction coil supplied with a radio-frequency electric current. A flow of argon gas (usually
13 to 18 liters per minute) is introduced between the two outermost tubes of the torch and
an electric spark is applied for a short time to introduce free electrons into the gas stream.
These electrons interact with the radio-frequency magnetic field of the induction coil and
are accelerated first in one direction, then the other, as the field changes at high frequency
(usually 27.12 million cycles per second). The accelerated electrons collide with argon
atoms, and sometimes a collision causes an argon atom to part with one of its electrons.
The released electron is in turn accelerated by the rapidly changing magnetic field. The
process continues until the rate of release of new electrons in collisions is balanced by the
rate of recombination of electrons with argon ions (atoms that have lost an electron). This
produces a ‘fireball’ that consists mostly of argon atoms with a rather small fraction of
free electrons and argon ions. The temperature of the plasma is very high, of the order of
10,000 K. The plasma also produces ultraviolet light, so for safety should not be viewed
directly.
The ICP can be retained in the quartz torch because the flow of gas between the
two outermost tubes keeps the plasma away from the walls of the torch. A second flow of
argon (around 1 liter per minute) is usually introduced between the central tube and the
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intermediate tube to keep the plasma away from the end of the central tube. A third flow
(again usually around 1 liter per minute) of gas is introduced into the central tube of the
torch. This gas flow passes through the centre of the plasma, where it forms a channel that
is cooler than the surrounding plasma but still much hotter than a chemical flame. Samples
to be analyzed are introduced into this central channel, usually as a mist of liquid formed
by passing the liquid sample into a nebulizer.
To maximise plasma temperature (and hence ionisation efficiency) and stability,
the sample should be introduced through the central tube with as little liquid (solvent
load) as possible, and with consistent droplet sizes. A nebuliser can be used for liquid
samples, followed by a spray chamber to remove larger droplets, or a desolvatingnebuliser
can be used to evaporate most of the solvent before it reaches the torch. Solid samples can
also be introduced using laser ablation. The sample enters the central channel of the ICP,
evaporates, molecules break apart, and then the constituent atoms ionise. At the temperatures
prevailing in the plasma a significant proportion of the atoms of many chemical elements
are ionized, each atom losing its most loosely bound electron to form a singly charged ion.
The plasma temperature is selected to maximiseionisation efficiency for elements with a
high first ionisation energy, while minimising second ionisation (double charging) for
elements that have a low second ionisation energy.
Mass spectrometry
For coupling to mass spectrometry, the ions from the plasma are extracted through
a series of cones into a mass spectrometer, usually a quadrupole. The ions are separated on
the basis of their mass-to-charge ratio and a detector receives an ion signal proportional to
the concentration.
The concentration of a sample can be determined through calibration with certified
reference material such as single or multi-element reference standards. ICP-MS also lends
itself to quantitative determinations through isotope dilution, a single point method based
on an isotopically enriched standard.
Other mass analyzers coupled to ICP systems include double focusing magnetic-
electrostatic sector systems with both single and multiple collector, as well as time of
flight systems (both axial and orthogonal accelerators have been used).
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Applications
One of the largest volume uses for ICP-MS is in the medical and forensic field,
specifically, toxicology. A physician may order a metal assay for a number of reasons,
such as suspicion of heavy metal poisoning, metabolic concerns, and even hepatological
issues. Depending on the specific parameters unique to each patient’s diagnostic plan,
samples collected for analysis can range from whole blood, urine, plasma, serum, to even
packed red blood cells. Another primary use for this instrument lies in the environmental
field. Such applications include water testing for municipalities or private individuals all
the way to soil, water and other material analysis for industrial purposes.
In recent years, industrial and biological monitoring has presented another major
need for metal analysis via ICP-MS. Individuals working in plants where exposure to
metals is likely and unavoidable, such as a battery factory, are required by their employer
to have their blood or urine analyzed for metal toxicity on a regular basis. This monitoring
has become a mandatory practice implemented by OSHA, in an effort to protect workers
from their work environment and ensure proper rotation of work duties (i.e. rotating
employees from a high exposure position to a low exposure position).
Regardless of the sample type, blood, water, etc., it is important that it be free of
clots or other particulate matter, as even the smallest clot can disrupt sample flow and
block or clog the sample tips within the spray chamber. Very high concentrations of salts,
e.g. sodium chloride in sea water, can eventually lead to blockages as some of the ions
reunite after leaving the torch and build up around the orifice of the skimmer cone. This
can be avoided by diluting samples whenever high salt concentrations are suspected, though
at a cost to detection limits.
ICP-MS is also used widely in the geochemistry for radiometric dating, in which it
is used to analyze relative abundance of different isotopes, in particular uranium and lead.
ICP-MS is more suitable for this application than the previously usedthermal ionization
massspectrometry,asspecieswithhigh ionization energy such as osmium and tungsten can
be easily ionized. For high precision ratio work, multiple collector instruments are normally
used to reduce the effect noise on the calculated ratios.
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In the field of flow cytometry, a new technique uses ICP-MS to replace the
traditional fluorochromes. Briefly, instead of labelling antibodies (or other biological
probes) with fluorochromes, each antibody is labelledwith a distinct combinations of
lanthanides. When the sample of interest is analysed by ICP-MS in a specialised flow
cytometer, each antibody can be identified and quantitated by virtue of a distinct ICP
“footprint”. In theory, hundreds of different biological probes can thus be analysed in an
individual cell, at a rate of ca. 1,000 cells per second. Because elements are easily
distinguished in ICP-MS, the problem of compensation in multiplex flow cytometry is
effectively eliminated.
In the pharmaceutical industry, ICP-MS is used for detecting inorganic impurities
in pharmaceuticals and their ingredients. New and reduced maximum permitted exposure
levels of heavy metals form dietary supplements, introduced in USP (United States
Pharmacopeia) <232>Elemental Impurities—Limits [1] and USP <233>Elemental
Impurities—Procedures,[2] will increase the need for ICP­MS technology, where, previously,
other analytic methods have been sufficient.
Elemental analysis
The ICP-MS allows determination of elements with atomic mass ranges 7 to 250
(Li to U), and sometimes higher. Some masses are prohibited such as 40 due to the
abundance of argon in the sample. Other blocked regions may include mass 80 (due to the
argon dimer), and mass 56 (due to ArO), the latter of which greatly hinders Fe analysis
unless the instrumentation is fitted with a reaction chamber. Such interferences can be
reduced by using a high resolution ICP-MS (HR-ICP-MS) which uses two or more slits
constrict the beam and distinguish between nearby peaks. This comes at the cost of
transmission, for example to distinguish Iron from Argon by take a resolving power of
10,000, which may reduce the Iron transmission by around 99%.
A single collector ICP-MS may use a multiplier in pulse counting mode to amplify
very low signals, an attenuation grid or a multiplier in anologue mode to detect medium
signals, and a Faraday cup/bucket to detect larger signals. A multi-collector ICP-MS may
have more than one of any of these, normally Faraday buckets which are much less
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expensive. With this combination, a dynamic range of 12 orders of magnitude, from 1 ppq
to 100 ppm is possible.
ICP-MS is a method of choice for the determination of cadmium in biological
samples.[4] Unlike atomic absorption spectroscopy, which can only measure a single element
at a time, ICP-MS has the capability to scan for all elements simultaneously. This allows
rapid sample processing. A simultaneous ICP-MS that can record the entire analytical
spectrum from lithium to uranium in every analysis won the Silver Award at the 2010 Pittcon
Editors’ Awards. An ICP-MS may use multiple scan modes, each one striking a different
balance between speed and precision. Using the magnet alone to scan is slow, due to
hysteresis, but is precise. Electrostatic plates can be used in addition to the magnet to
increase the speed, and this, combined with multiple collectors, can allow a scan of every
element from Lithium 6 to Uranium Oxide 256 in less than a quarter of a second. For low
detection limits, interfering species and high precision, the counting time can increase
substantially. The rapid scanning, large dynamic range and large mass range is ideally
suited to measuring multiple unknown concentrations and isotope ratios in samples that
have had minimal preparation (an advantage over TIMS), for example seawater, urine,
and digested whole rock samples. It also lends well to laser ablated rock samples, where
the scanning rate is so quick that a real time plot of any number of isotopes is possible.This
also allows easy spatial mapping of mineral grains.
Sample introduction
The first step in analysis is the introduction of the sample. This has been achieved
in ICP-MS through a variety of means.
The most common method is the use of analytical nebulizers. Nebulizer converts
liquids into an aerosol, and that aerosol can then be swept into the plasma to create the
ions. Nebulizers work best with simple liquid samples (i.e. solutions). However, there
have been instances of their use with more complex materials like a slurry. Many varieties
of nebulizers have been coupled to ICP-MS, including pneumatic, cross-flow, Babington,
ultrasonic, and desolvating types. The aerosol generated is often treated to limit it to only
smallest droplets, commonly by means of a Peltier cooled double pass or cyclonic spray
chamber. Use of autosamplers makes this easier and faster, especially for routine work
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and large numbers of samples. A DesolvatingNebuliser (DSN) may also be used; this uses
a long heated capillary, coated with a fluoropolymer membrane, to remove most of the
solvent and reduce the load on the plasma. Matrix removal introduction systems are
sometimes used for samples, such as seawater, where the species of interest are at trace
levels, and are surrounded by much more abundant contaminants.
Laser ablation is another method. While being less common in the past, is rapidly
becoming popular has been used as a means of sample introduction, thanks to increased
ICP-MS scanning speeds. In this method, a pulsed UV laser is focused on the sample and
creates a plume of ablated material which can be swept into the plasma. This allows
geochemists to spacially map the isotope composition in cross-sections of rock samples, a
tool which is lost if the rock is digested and introduced as a liquid sample. Lasers for this
task are built to have highly controllable power outputs and uniform radial power
distributions, to produce craters which are flat bottomed and of a chosen diameter and
depth.
For both Laser Ablation and DesolvatingNebulisers, a small flow of Nitrogen may
also be introduced into the Argon flow. Nitrogen exists as a dimer, so has more vibrational
modes and is more efficient at receiving energy from the RF coil around the torch.
Other methods of sample introduction are also utilized. Electrothermal vaporization
(ETV) and in torch vaporization (ITV) use hot surfaces (graphite or metal, generally) to
vaporize samples for introduction. These can use very small amounts of liquids, solids, or
slurries. Other methods like vapor generation are also known.
Plasma torch
The plasma used in an ICP-MS is made by partially ionizing argon gas (Ar ’! Ar+ +
e”). The energy required for this reaction is obtained by pulsing an alternating electric
current in wires that surround the argon gas.
After the sample is injected, the plasma’s extreme temperature causes the sample
to separate into individual atoms (atomization). Next, the plasma ionizes these atoms (M
’! M+ + e”) so that they can be detected by the mass spectrometer.
An inductively coupled plasma (ICP) for spectrometry is sustained in a torch that
consists of three concentric tubes, usually made of quartz. The two major designs are the
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Fassel and Greenfield torches.The end of this torch is placed inside an induction coil
supplied with a radio-frequency electric current. A flow of argon gas (usually 14 to 18
liters per minute) is introduced between the two outermost tubes of the torch and an electrical
spark is applied for a short time to introduce free electrons into the gas stream. These
electrons interact with the radio-frequency magnetic field of the induction coil and are
accelerated first in one direction, then the other, as the field changes at high frequency
(usually 27.12 MHz). The accelerated electrons collide with argon atoms, and sometimes
a collision causes an argon atom to part with one of its electrons. The released electron is
in turn accelerated by the rapidly changing magnetic field. The process continues until the
rate of release of new electrons in collisions is balanced by the rate of recombination of
electrons with argon ions (atoms that have lost an electron). This produces a ‘fireball’ that
consists mostly of argon atoms with a rather small fraction of free electrons and argon
ions.
Advantage of argon
Making the plasma from argon, instead of other gases, has several advantages.
First, argon is abundant (in the atmosphere, as a result of the radioactive decay of potassium)
and therefore cheaper than other noble gases. Argon also has a higher first ionization
potential than all other elements except He, F, and Ne. Because of this high ionization
energy, the reaction (Ar+ + e” ’! Ar) is less energetically favorable than the reaction (M+ +
e” ’! M). This ensures that the sample remains ionized (as M+) so that the mass spectrometer
can detect it.
Argon can be purchased for use with the ICP-MS in either a refrigerated liquid or
a gas form. However it is important to note that whichever form of argon purchased, it
should have a guaranteed purity of 99.9% Argon at a minimum. It is important to determine
which type of argon will be best suited for the specific situation. Liquid argon is typically
cheaper and can be stored in a greater quantity as opposed to the gas form, which is more
expensive and takes up more tank space. If the instrument is in an environment where it
gets infrequent use, then buying argon in the gas state will be most appropriate as it will be
more than enough to suit smaller run times and gas in the cylinder will remain stable for
longer periods of time, whereas liquid argon will suffer loss to the environment due to
venting of the tank when stored over extended time frames. However if the ICP-MS is to
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be used routinely and is on and running for eight or more hours each day for several days
a week, then going with liquid argon will be the most suitable. If there are to be multiple
ICP-MS instruments running for long periods of time, then it will most likely be beneficial
for the laboratory to install a bulk or micro bulk argon tank which will be maintained by a
gas supply company, thus eliminating the need to change out tanks frequently as well as
minimizing loss of argon that is left over in each used tank as well as down time for tank
changeover.
There are rare ICP-MS solutions that utilize helium for plasma generation.
Transfer of ions into vacuum
The carrier gas is sent through the central channel and into the very hot plasma.
The sample is then exposed to radio frequency which converts the gas into a plasma. The
high temperature of the plasma is sufficient to cause a very large portion of the sample to
form ions. This fraction of ionization can approach 100% for some elements (e.g. sodium),
but this is dependent on the ionization potential. A fraction of the formed ions passes
through a ~1 mm hole (sampler cone) and then a ~0.4 mm hole (skimmer cone). The
purpose of which is to allow a vacuum that is required by the mass spectrometer.
The vacuum is created and maintained by a series of pumps. The first stage is
usually based on a roughing pump, most commonly a standard rotary vane pump. This
removes most of the gas and typically reaches a pressure of around 133 Pa. Later stages
have their vacuum generated by more powerful vacuum systems, most often turbomolecular
pumps. Older instruments may have used oil diffusion pumps for high vacuum regions.
Sample preparation
For most clinical methods using ICP-MS, there is a relatively simple and quick
sample prep process. The main component to the sample is an internal standard, which
also serves as the diluent. This internal standard consists primarily of deionized water,
with nitric or hydrochloric acid, and Indium and/or Gallium. Depending on the sample
type, usually 5 ml of the internal standard is added to a test tube along with 10–500
microliters of sample. This mixture is then vortexed for several seconds or until mixed
well and then loaded onto the autosampler tray. For other applications that may involve
very viscous samples or samples that have particulate matter, a process known as sample
digestion may have to be carried out, before it can be pipetted and analyzed. This adds an
extra first step to the above process, and therefore makes the sample prep more lengthy.
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4.3.PRECLINICAL  TOXICOLOGICAL  STUDY  OF  PAVALA
VEERACHUNNAM ON RAT
ACUTE  ORAL  TOXICITY STUDY (LD50 Determination)
Experimental Animals
Adult albino wistar rats of either sex weighing around 125-180gms were used.
The animals were maintained at normal room temperature with a humidity of 55 +5%. All
the animals were fed with pellet diet obtained from Poultry Research Station, Nandanam,
Chennai - 35 and tap water ad libitum throughout the experimental period. The animals
were acclimatized to the laboratory conditions before experimental procedures were started.
The experimental protocol for the Pavalaveerachunnam , were approved by the  college
of Annai Velankanni Pharmacy college,Chennai.
For carrying out oral toxicity study Organization for economic cooperation
andDevelopment (OECD) guidelines 423 were followed. It is a stepwise procedure with
three animals of a single sex per step. Depending on the mortality and/or morbidity of the
animals a few steps may be necessary to judge the toxicity of the test substance. This
procedure has advantage over other methods because of minimal usage of animals while
allowing for acceptable data. The method uses defined doses (5, 50, 300, 2000mg/kg body
weight) and the results allow a substance to be ranked and classified according to the
globally harmonized system. The starting dose of Pavalaveerachunnam was 2000mg/kg
bodyweight p.o. The dose was administered to the rats which were fasted overnight with
water ad libitum and observed for signs of toxicity. The same dose was once again tried
with another three rats and were observed for 72 hours for symptoms like change in skin
color, salivation, diarrhea, sleep, tremors, convulsions and also respiratory, autonomic
and CNS effects.
SUB  ACUTE TOXICITY STUDY (OECD GUIDELINES 423)
Humans are more often exposed to chemicals at levels much lower than those that
are actually fatal, but they are exposed over longer periods of time. To assess the nature of
the toxic effects under these more realistic situations, short term and long term toxicity
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studies are conducted. Equal number of males and females should be used. Generally at
least 6 rats are used in each dose group as well as control group.
Route of administration
 The test drug (Pavalaveerachunnam) should be administered by the route of the
intended use or exposure in humans. For most chemicals the most preferred route is the
oral route. The preferred procedure is to incorporate the chemical in the diet, although the
drinking water is sometimes used as a vehicle. The latter method is advisable when the
chemical may react with a component in the diet. The chemical may be administered by
oral gavage needle.
Dosage and duration
Since the aim of these studies is to determine the nature and site of the toxic effects
as well as the “no-effect level”, it is advisable to select three doses. These doses are generally
selected on the basis of the information obtained in the acute toxicity studies.
Observations and examinations
Body weight and food consumption
These should be determined weekly. Decreased body weight gain is simple yet
sensitive index of toxic effects. Food consumption is also a useful indicator. In addition a
marked decrease in the consumption can induce effects that mimic or aggravate the toxic
manifestations of the chemical.
General observations
These should include appearance, behavior, and any abnormality. Dead and
Moribund animals should be removed from the cages for gross and possibly for microscopic
examination. Frequent observation is necessary to minimize cannibalism.
Laboratory tests
Hematologic examinations generally include hematocrit, hemoglobin,
erythrocytecount, total leukocyte count, and differential leukocytes count. Clinical
laboratory tests usually include fasting blood glucose, Aspartate aminotransferase (AST),
Alanine aminotransferase (ALT) alkaline phosphatase (ALP) , total Bilirubin (tb), blood
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urea creatinine, uric acid and other elements such as sodium, potassium, calcium, and
phosphorous.
Procedure
 Adult healthy albino rats of either sex weighing 125-180 g were selected for the
study. The rats were divided into Three groups of six animals each. The drug was
administered in doses of 200 and 400 mg/kg daily once in the morning for 28days. Group
I received the vehicle (Normal Saline) once daily and served as solvent control. Group II
and III receivedPavalaveerachunnamwith Honey once daily in a dose of 200 and 400
mg/kg respectively. The animals were placed in cages and the body weight and feed
consumption were recorded frequently. Simultaneously observation was made for any
toxic symptoms or mortality.
 On 29th day animals were anesthetized by intra peritoneal (i.p) administration of
thiopental sodium and blood was collected by retro-orbital puncture and the serum was
separated. Hematological parameters like RBC, WBC and Hb were estimated from blood.
The serum was subjected to biochemical analysis like aspartate aminotransferase (AST),
alanine amino transferase (ALT), alkaline phosphatase, (ALP) total bilirubin, urea, uric
acid and creatinine. Vital organs like liver, Brain, Heart, lungs and kidneys, were dissected
out carefully; extra tissues and blood were removed, observed for pathological changes
and weighed. It was kept in 10% formalin and subjected for histopathological analysis.
Instruments used
Auto analyzer
Semi auto analyzer ERBA, was used to estimate biochemical parameters viz.
Aspartate Aminotransferase (AST), Alanine Aminotransferase (ALT), Alkaline Phosphates
(ALP), Total Bilirubin (TB), Urea, creatinine, uric acid.
Hematological studies
The following hematological parameters were estimated by standard procedures.
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Estimation of Total R.B.C. count (Ghai, C.L. (1993).
The enumeration of red blood corpuscles was carried out on blood samples using
haemocytometer as per standard methods. The blood was taken in the R.B.C. pipette up to
0.5 marks and diluted with R.B.C. diluting fluid (Hyme’s fluid) up to 101 marks. It was
mixed well and mounted on Neubauer’s counting chamber. The red blood cells were then
counted using a microscope and their number in undiluted blood was calculated. R.B.C.
count in blood is expressed as cells in millions/mm3.
Estimation of Total W.B.C. Count (Ghai. 1993).
The blood was taken in W.B.C. pipette up to 0.5 mark and diluted with W.B.C.
diluting fluid (1-2% acetic acid stained lightly with gentian violet), where acetic acid
destroy the red blood corpuscles and gentian violet stains the nuclei of white blood cells.
The fluid in the pipette was mixed well and mounted in the counting chamber. The W.B.C.
count was then counted and their number in undiluted blood was calculated. W.B.C. count
in blood is expressed as cells in 1000/mm3
Estimation of Hemoglobin (Hb) concentration (Ghai. 1993).
Haemoglobin in the red blood corpuscles was converted to acid haematin by adding
N/10 hydrochloric acid. The brown colour developed was matched against standard brown
tinted glass in the comparator by direct vision. The haemoglobin concentration in blood is
expressed as grams per 100 ml of blood (g%).
Serum Analysis
The serum was analysed for the following parameters.
a. Aspartate Aminotransferase (AST )
b. Alanine Aminotransferase (ALT)
c. Alkaline Phosphatase (ALP)
d. Total Bilirubin (TB)
e. Urea
f. Creatinine
g. Uric Acid
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The separated serum was subjected to biochemical analysis by ERBA diagnostic kit
for the following parameters like urea, uric acid, creatinine, total bilirubin AST, ALT, ALP.
Estimation of urea
 Estimation of urea was carried out using ERBA kit by the urease method.
Urea Reagent
 A-ketoglutarate 75 mmol/L
NADH                                               0.32 mmol/L
Urease                                              > 8.00 IU/L
GLDH                                                > 1.00 IU/L
ADP                                                  1.2 mmol/L
aTris Buffer pH 7.9 ± 0.1 at 25°C    100 mmol/L
Urea standard
Urea                                                  50mg/dl
Assay Procedure
Two test tubes were marked as standard and test. 1000 L of working reagent was
pipetted into both the test tubes. 20 L of standard urea was added to the standard test tube.
20 L of serum was added to the other test tube. A blank was also prepared with distilled
water. It was then mixed well and the absorbant was monitored at 340 nm. The change in
absorbance for the standard and the test were calculated using the formula
A   =A1  - A2
A of test
      Urea= ——————————— x Concentration of Standard (mg / dl)
A of standard
Uric acid
Uric acid was estimated using modified Trinder method using ERBA diagnostic kit.
Uric acid reagent
                    Abs.of test
Uric acid (mg/dl) = ———-——- x Concentration of Standard(mg /dl)
                  Abs. of standard
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4-aminoantipyrine 0.5 mmol/L
TBBH 1.75 mmol/L
Uricase 120 IU/L
Peroxidase 500 IU/L
Tris buffer pH 8.25 ± 0.1 at 20°C 50 mmol/L
 Uric acid standard 6mg/dl (0.36 mmol/L)
Assay Procedure
Three test tubes were marked as blank, standard and test. 1000 μL of working
reagent was added to all the three test tubes. 20 μL of distilled water was added to the
blank. 20 μL of standard uric acid solution was added to the standard test tube. To the test
20 μL of serum was added. It was then mixed well and incubated for 5 mins at 37° C. The
absorbance of standard and each test were read at 505 nm against a reagent blank.
Creatinine
Creatinine was estimated by Jaffe’s method using ERBA diagnostic kit.
Reagent 1: picric acid reagent
Picric acid 25.8 mmol/L
Reagent 2: sodium hydroxide reagent
Sodium hydroxoide95 mmol/L
Creatinine standard
Creatinine - 2mg/dl (0.166 mmol /L). Equal Volumes of reagent 1 and 2 were
mixed and waited for 15 minutes before use.
Procedure
Two test tubes were marked as standard and test. 1000 μ L of working reagent was added
to both the test tubes. To the standard test tube 100 μ L  ofcreatinine and to the test 100 μ
L  of serum were added. It was then mixed well and the initial absorbance (Al) was read
immediately. After 80 sees the final absorbance (A2) was read after mixing at 505 nm. A
=A - A1
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A  of Test
Creatinine  ————-——————— x     Concentration of Standard (mg
A  of Standard
Liver function tests
Bilirubin (Diazo method)
Total biliriubin was estimated by diazo method using ERBA diagnostic kit.
Principle
Biliriubin reacts with diazotized sulphanilic acid in acidic medium to form pink
coloredazobilirubin with absorbance directly proportional to bilirubin concentration.
Reagent composition
Reagent 1: Total biliriubin reagent
Surfactant                1.000%
Hcl                           100 mmol/L
Sulphanilic acid       5 mmol/L
Reagent 2: Direct biliriubin reagent
Sulphanilic acid 10 mmol/L
Hcl 100 mmol/L
Reagent 3: Sodium nitrite reagent
Sodium nitrite 144 mmol/L
Reagent preparation
Total biliriubin (vol 25 ml) = 25 ml reagent 1 + 0.5 ml reagent 3
Assay procedure
 3 test tubes were taken and labelled as blank, standard and test. 500 μl of working
reagent was added to all the three test tubes. 25 μl of distilled water was added to blank, 25
μl of standard solution was added to the standard and 25 μl of serum was added to the test.
It was mixed well and incubated for 5mins at 37°C. The absorbance was read at 546 nm
against reagent blank.
T. biliriubin (mg/dl) = (Absorbance of test/ Absorbance of standard) x Conc of std(mg/dl)
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Aspartate aminotransferase (AST)
AST was estimated by International Federation Of Clinical Chemistry (IFCC)
method using ERBA diagnostic kit. AST occurs in all human tissues like liver, kidney,
heart and skeletal muscle.
Reagent composition
Reagent 1: AST reagent
2- oxoglutarate 12 mmol/L
L- aspartate 200 mmolL
MDH  545 U/L
 LDH  909 U/L
NADH 0.18 mmol/L
Tris buffer pH 7.8 80 mmol/L
EDTA 5 mmol/L
Assay procedure
1000 μ l  of working reagent after reconstitution was added to a test tube and 100
μ l of serum was added to it, mixed well and aspirated. The absorbance was read at 340
nm. The absorbance change was converted to international units using the formula
A /min )  x total reaction volume x 103
    IU/L = ——————————————————
                         Sample volume absorptivity  x P
Alanine aminotransferase (ALT )
 ALT was estimated by International Federation Of Clinical Chemistry (IFCC) method
using ERBA diagnostic kit.
Reagent composition
Reagent: ALT reagent
 L- alanine 500 mnol/L
NADH (yeast) 0.18 mmol/L
 LDH >1820 IU/L
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2-oxoglutarate 12 mmol/L
Tris buffer pH 7.5  80 mmol/L
Assay procedure
1000 μ l of working reagent after reconstitution was added to a test tube and 100 μ
l of serum was added to it and mixed well and aspirated. The absorbance was read at 340
nm. International units (IU) of activity was calculated using the formula
A /min )  x total reaction volume x 103
 IU/L = —————-—————————————
                  Sample volume x  absorptivity  x P
Alkaline phosphatase
Alkaline phosphatase was estimated by p-Nitrophenyl phosphate (pNPP kinetic method)
Principle
 ALP at  an alkaline pH, hydrolyses P-nitrophenylphosphate to form
P-nitrophenoland phosphate. The rate of formation of p-nitro phenol is measured as an
increase in absorbance which is proportional to the ALP activity in the sample.
Working reagent 1: substrate tablet was dissolved in 3.2 ml of buffer reagent. (10x3 ml
pack) 1 ml of working reagent was pipetted out in to a clean dry test tube and 0.02 ml of
serum was added, mixed well and initial absorbance Ao was observed after lmin. The
absorbance reading was repeated every 1, 2 and 3 min. The mean absorbance change per
min( A /min) was calculated using the formula ALP activity inU/ L  =A/min-2754
Histopathology
Liver, lungs, spleen and kidneys were evaluated for histopathological changes.
After collection of organs, the tissues were stored in 10% formalin for 48 hrs. The solution
was changed after 24 his. In the case of kidneys, two incomplete parallel cuts were made
from cortex to pelvis and one longitudinal cut was made which divides the kidney into
two halves. In the case of liver one piece from each lobe was used. The tissues were then
wax embedded. The tissues were then wax embedded as below:
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Solvent Duration
50% Alcohol  Holding Period
70% Alcohol 30 minutes
95% Alcohol  20 minutes
100% Alcohol 30 minutes
Chloroform  30 minutes
Wax 10 minutes
They were then blocked in wax and allowed to set on a cold plate. One cooled they
were cut into 5u size sections. The sections were kept in slides and stained with
haematoxyline and eosin.
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4.4 PHARMACOLOGICAL STUDY
HEPATOPROTECTIVE ACTIVITY OF PAVALAVEERA CHUNNAM
PARACETAMOL- INDUCED LIVER DAMAGE IN RATS PROCEDURE
Paracetamol is one of the most commonly and widely used analgesic, anti-pyretic
drug, which shows a high margin of safety. However, when used in high doses it can lead
to hepatic damage, It gets metabolized to an active metabolite N-acetyl-p-benzoquinone
imine by the cytochrome-p-450 microsomal enzyme system,which results in an oxidative
stress producing liver glutathione and glycogen depletion and hepatic.
Methodology
Wister rats of either sex weighing 150-200g are used. Paracetamol 2g/kg body
weight is administered orally as a single dose. The animals are given the test drug for 6
days prior to Paracetamol administration and on the seventh day along with paracetamol.
The animal are sacrificed after 24 hrs and the blood /serum is used for biochemical analysis
and the liver for histopathological studies
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HYPOLIPIDEMIC ACTIVITY OF PAVALAVEERA CHUNNAM
Cholesterol- Diet induced Hyperlipedemia in mice
Hyperlipidemia is the one of the major risk factor for the development of coronary
heart disease. Currently available hyperlipidemic drugs have been associated with number
of side effects. A number of herbal medicines are used for controlling hyperlipidemia
because of the undesirable side effects and contraindications of synthetic drug
Methodology
Swiss albino Mice of either sex weighing 20-3Ogm are fed on a cholesterol diet
consisting of cholesterol (l%),Sodium cholate(0.5%), sucrose(30%), cascien(10%),
butter(5%) and standard chow (53.5%) for seven days. The animals are divided in 5 groups
of control, test drug and standard treated animals. Group I Received Normal saline and
served as control. Group II - positive control (400mg/kg.p.o)Cholesterol induced diet,
Group III - Group II + Atorvastatin (13mg/kg.p.o),Group IV - Group II + Sample drug
200mg/kg bw, Group V- Group II +Sample drug 400mg/kg bw, The study is considered in
two stages, in the preliminary stage effective hypolipedemic doses of test and standard
drugs are worked out and in the final stage the effect of test and standard drugs are studied
in three graded doses depending upon the results of preliminary stage and the LD 50 of
test compound. Finally the LD test and standard drugs are calculated to assess relative
potency of the test. The lipid profile includes total cholesterol, LDL, HDL, Triglycerides.
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DIURETIC ACTIVITY OF PAVALAVEERA CHUNNAM(LIPSCHITZ TEST)
PROCEDURE
Healthy adult Wister male rats of weighing 150-200 g procured from the animal
house of - College of Pharmacy  were used for the study. The animals were maintained in
well ventilated room temperature with natural 12 + 12 day and night cycle in the
polypropylene cages. The animals were fed with balanced diet that is standard rodent
pellet diet (Hindustan Lever Ltd.) and water ad libitum.
The animals were housed for 1 week prior to the experiment to acclimatize to the
laboratory conditions. Approval for the research work and ethical clearance was obtained
from the College of Pharmacy, (Ethical Committee  No SBCP / 2015-2016/ CPCSEA).
Wistar rats were divided into 4 groups (6 each). The animals of group (I) served as normal
control (Vehicle) which received normal saline water (2 ml/kg b.w., orally) only. The
animals of group (II) served as standard control which received frusemide (5mg/kg b.w.,
orally). Groups (III) received sample drug 200mg/kg bw. Group(IV) received sample drug
400mg/kg bw-orally. The method is based on water and sodium excretion in test animals
as compared to rats treated with high dose of urea. The method of Lipschitz et al. was
employed for the assessment of diuretic activity. Male Wistar rats weighing 150 to 200 g
were used. They were placed in metabolic cages provided with a wire mesh bottom and a
funnel for collecting the urine. Stainless steel sieves were placed in the funnel to retain the
feces, allowing only urine to flow down for collection and measurement. The food and
water are withdrawn 15 h prior to the test. Three animals were placed in one metabolic
cage. The rats of each group were treated with drugs as per the details mentioned above.
Additionally 5 ml of normal saline solution per 100 g was administered orally to all rats.
Urine excretion was recorded after 15mts,30mts,lhr,2hr,3hr and 4hr. The sodium and
potassium contents of the collected urine were estimated by Flame Photometer (Toshniwal
group model TCM-35). The instrument was calibrated with standard solutions containing
different concentrations of Na+ and K+. The conductivity was directly determined on
fresh urine samples using a conductometer (Toshniwal group model TCM-15). PH was
measured with a digital pH meter (MK-VI, Unique instruments & machineries, Calcutta)
on fresh urine sample.
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LITHOTRIPTIC ACTIVITY OF PAVALAVEERA CHUNNAM
Experimental animals
Adult male albino rats of Wistar strains, weighing between 150 – 250g, obtained
from Small Animal Breeding Center, were used for the experimental studies. The animals
were acclimatized to the animal house condition for ten days. The animals were fed with
commercial rat field and water was given ad libitum.
Experimental induction of calcium oxalate lithiasis in rats
The method adopted was that of Chow et al. (1975).
Preparation of calculi producing diet (CPD)
The method adopted was that of Chow et al. (1975). Commercial rat feed was
finely powdered, supplemented with sodium glycollate (3 % concentration, w/w) and
pelleted with water. The pellets were dried in an oven at 30°C for 2 days and used as the
calculi producing diet.
Experimental setup
The animals were divided into 4 groups comprising of six animals in each. Group
I Received Normal saline and served as control. Group 11- Negative control (70mg/
kg.p.o)CPD , Group III – Cystone (500mg/kg.p.o) Group IV - Sample drug 200mg/kg bw,
Group V- Sample drug 400mg/kg bw, Rats fed with CPD for 30 days to induce stone
formation. After the experimental period, 24 h urine samples were collected using
hydrochloric acid as preservative. The animals were sacrificed by decapitation, liver and
kidneys were excised from the body and their weights were recorded, a small portion of
both kidney and Jiver tissues were preserved for histo pathological and electron microscopic
studies
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4.5.ANTI-MICROBIAL ACTIVITIESBY KIRBY BAUER  METHOD
Aim:
      The antimicrobial activity of Pavalaveerachunnam was adapted through Kirby-Bauer
method(Agar diffusion testing).
Components of Muller Hinton agar medium:
         Beef extract - 2gm/lit
         Acid Hydrolysate of Casein - 17.5 gm/lit
         Starch - 1.5 gm/lit
         Agar – 17gm/lit
         Distilled water - 1000 ml
         PH - 7.3  0.1 at 250C
Procedure:
The sterilized (autoclaved at 1200C for 30 min) medium (40-500C) was
inoculated (1 ml/100 ml of medium) with the suspension (150 cells per ml) of the
Micro-organism (matched to McFarland turbidity standard) and poured in to a Petri
dish to give depth of 3-4 mm. The paper saturated with the test compounds -
Pavalaveerachunnamwas placed on the solidified medium.The plates were pre
incubated for 1 hour at room temperature and incubated at 370C for 24 and 48 hours
for anti-bacterial activities respectively. Amikacin is used as standard for anti-bacterial
and Ketokonazole is used as standard for anti-fungal respectively at the concentration
of 50 mcg / disc standard for an In-vitro antimicrobial activity of Pavalaveerachunnam
was screened against bacteria strains such as Klebsiellaaerogenes Staphylococcus
pyogenes, Escherichia coli, Staphylococcus albus, Salmonella typhi, Proteus vulgaris,
p.aeruginosa and fungal strain Candida albicans.
           The prepared disc ofPavalaveerachunnam are placed over the incubated plate using
sterile forceps and incubated for 24 hours at 370C. The plates after 24 hours incubation are
observed for the zone of inhibition.
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5. RESULT AND DISCUSSION
The Siddha mineral animal drug Pavalaveera Chunnam had been subjected to
various studies to establish the works of Siddhars to be true. Literary collections,
physicochemical and Elemental analysis, toxicological study, pharmacological study and
clinical study are done to prove the activity of Pavalaveera Chunnam in
Hepatoprotective,Hypolipidemic,Diuretic and  Lithotriptic activities.
The experimental analysis was done to standardize the Pavalaveera Chunnam  by
its chemical compounds and particle size.
SIDDHA STANDARDIZATION METHODS:
Siddhars used these following standardization methods to ensure the safety and
efficacy of the Chunnam. It shows the effectiveness of the drug.
Table No:4 Results of Siddha standardization
S.No Parameter Results of VP Interpretation
1. Colour Mild grey colour, Indicates complete calcination
no shining process
2. Odour Odourless Indicates complete calcination
process
3. Taste Tasteless Indicates complete
calcinations  process
4. Finger Print Test Impinged in the Indicates fine particles of
furrow of fingers powder.
5. Floating on Water Floats on water Lightness of drug.
6. Lustre Lustreless No glowing particles seen.lt
indicates complete calcinations
process
D The test drug PVC being .tasteless, odourless, lusterless and irreversible on heating,
indicates complete calcinations process.
D It is an ideal colour for Chunnam. Without shining indicates no free form of metals
present in that drug.
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D The test drug which was float on water has less specific gravity, possesses specific
gravity less than the water.
D On Finger print test, Only the particles which are in micro fine size that can enter
into the furrows of the finger print.
D PVC getting impinged in the furrows of fingerprint, indicates presence of microfine
particles and complete calcinations process
AS PER MODERN  STANDARDIZATION METHODS
Table No 5:Organoleptic characters of Pavalaveerachunnam
S.NO Parameter Result 
1. Colour in daylight White colour 
2. Appearance Powder 
3. Sense on touch Nice 
4. Sense on smell Odorless 
5. Sense on taste Taste less 
6. Solubility Sparingly soluble in water and well soluble 
in acids (con.HCl and con.H2SO4) 
7. Action on heat No change 
8. Flame test No change 
 Action on heat:
No strong white furmes evolved indicating the absence of carbonate
Flame test:
No bluish green flame appeared indicating absence of copper.
4.2.2.1 PHYSICO-CHEMICAL ANALYSIS:
1. Determination of loss on drying (LOD)(Normal value -less than 8%)
Loss in weight on drying = 0%
The stability of a drug and its shelf-life are reliant to moisture content of that drug.
Determination of moisture (loss on drying) in a drug is one of the important tests in
pharmaceutical analysis (kasture A.V, 2008).
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‘Physico-chemical analysis of Pavalaveerachunnam showed that loss on drying
(LOD) is 0 % which shows that no moisture content present in the prepared medicine.
Increased moisture content is the issue for instability of drug and lesser shelf-life of a
drug. Since, Pavalaveerachunnamhas been well prepared it could get maximum stability
and better shelf-life. Longer shelf-life forChendurammentioned in siddha literature is
thus justified from the above observation.
2. Determination of ash values:
 A. Total ash content=3.9%(Normal value - less than 80%)
The ash limit tests are designed to measure the amount of residual substances
when a sample is ignited under the conditions specified in the individual monograph. A
high ash value is indicative of contamination, substitution, adulteration, or carelessness in
preparing the drug. The total ash values of Pavalaveerachunnamwere 3.9%, the value of
total ash in the formulation is comparatively low. The value of total ash indicates that the
inorganic contents of the formulation are below the limits. It signifies the ash value
determination as an important parameter to standardize the herbal drugs.
B. Acid insoluble ash=0.8% (Normal value -less than 60%)
The acid-insoluble ash limit test is designed to measure the amount of ash insoluble
to diluted hydrochloric acid. Acid-insoluble ash value of the prepared formulation (0.8%)
shows that a very small amount of the inorganic component is insoluble in acid. It indicates
that adulteration of raw ingredients by substances, such as silica and husk, is very less,
and a low acid-insoluble ash value may also affect the amount of the component absorbed
in the gastro-intestinal canal when taken orally.
The test drug Pavalaveera chunnamhaving, lower the acid insoluble value better
will be the drug quality.
3. Determination of Alcohol-soluble and water-soluble extractive values
Alcohol soluble and water soluble extractive values of Pavalaveerachunnam are
depicted in Table .5 which shows 43.3% of alcohol-soluble extractive value and 14.2% of
water-soluble extractive value of the formulation. Lesser water-soluble extractive value
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implies that alcohol is a better solvent of extraction for the formulation than water. The
results of Alcoholic and water soluble extracts of the formulation show that mineral contents
of the formulations are more soluble in alcohol than water and a lesser water soluble
extractive value (14.2%) of the formulation. Hence honey should be used as adjuvant for
this preparation.
Microbial Limit Tests:
Table No :6 Results for Microbial limit test on Pavalaveerachunnam:
S.No Microbes Colony 
measurements 
Normal limits 
1.  Total viable aerobic count 1.0 x104 col/g 1 x105 col/g 
2.  Total Enterobacteriaceae Nil 1 x103 col/g 
3. Total fungal count 1.0 x104 col/g  1 x104 col/g 
 Test for specific pathogen   
1. Salmonella sp Nil Nil 
2. Staphylococcus aureas Nil Nil 
3. E.coli Nil Nil 
4. Pseudomonas aeruginosa Nil Nil 
 
 Total viable aerobic counts within the normal level.
 Total Enterobacteriaceae counts within the normal level.
 Total fungal count within the normal level.
 Specific pathogens like Salmonella sp., Staphylococcus aureus, E.coli and
Pseudomonas aeruginosaare Nil.
Hence, the test drug is free from any microbial contamination and it has standard quality.
THIN LAYER CHROMATOGRAPHY:
Thin-layer chromatography (TLC) is a chromatographic technique that is useful
for separating organic compounds. Because of the simplicity and rapidity of TLC, it is
often used to monitor the progress of organic reactions and to check the purity of products.
TLC is a simple, quick, and inexpensive procedure that gives how many components are
PRECLINICAL STUDY OF PAVALAVEERA CHUNNAM 115
in a mixture. TLC is also used to support the identity of a compound in a mixture when the
Rf of a compound is compared with the Rf of a known compound (preferably both run on
the same TLC plate).Chromatography works on the principle that different compounds
will have different solubility and absorption to the two phases between which they are to
be partitioned. As the solvent rises by capillary action up through the adsorbent, differential
partitioning occurs between components of the mixture dissolved in the solvent the
stationary adsorbent phase. The more strongly a given component of a mixture is adsorbed
onto the stationary phase, the less time it will spend in the mobile phase and the more
slowly it will migrate up the plate.
TLC SHEET OF PAVALAVEERA CHUNNAM
Under UV 254mm and 366 mm
Figure :11 TLC SHEET OF PAVALAVEERA CHUNNAM
Interpretation
Under UV 254mm and 366mm TLC result shows RF value (0.93blue) indicates
the presents of various chemical compounds in this drug.
PRECLINICAL STUDY OF PAVALAVEERA CHUNNAM 116
CHEMICAL ANALYSIS:
Table No:7 Preliminary Basic and Acidic Radical Studies
Sl.No PARAMETERS RESULT 
1. Calcium Present 
2. Iron (ferric) Absent 
3. Iron (ferrous) Present 
4. Zinc  Absent 
5. Sulphate Present 
6. Chloride Present 
7. Phosphate Absent 
8. Carbonate Absent 
9. Starch  Absent 
10. Albumin Absent 
11. Tannic acid  Absent 
12. Unsaturated compounds Absent 
13. Reducing sugar Absent 
14. Amino acid  Absent 
15. Mercury Absent 
From the result of preliminary biochemical analysis reveals that trial drug –
Pavalaveerachunnam shows the presence of calcium, iron in  ferrous form, sulphate,
chloride, phosphate, and amino acid.
INTERPRETATION:
CALCIUM:
 Maintenance of plasma calcium level within normal range is of vital
importance because neuro-muscular excitability is dependent on plasma
calcium level.
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 Normal neuro-muscular excitability maintained by calcium present in the
test drug favours aphrodisiac activity
IRON: (Ferrous and Ferric form)
 Improves general nourishment
 Improves oxygen carrying capacity of the blood
 Hence, reduces fatigue and cures anemia
 Absorbed in ferrous form and converted to ferric form
 Thus, test drug meets the daily Iron requirement of our body. [male-10mg/day;
female-15-20mg/day]
CHLORIDE:
 Chloride forms the chief anion of the extracellular fluid and exists along with
sodium mostly.
 Regulates acid base balance
 Formation of HCl in gastric juice
 Help to preserve normal neuromuscular irritability by maintaining a state of
equilibrium, on account of their relative proportion in ECF and ICF.
PHOSPHORUS:
 It involves the function of repair of body cells especially hepatocytes
 It plays major role in structural frame work of DNA and RNA
 It is very much important for production of RBC from liver cells
 Contributes formation of ATP, ADP and creatine phosphate
 Formation of physiologically important phosphorus containing compounds
like phospholipids, co-enzymes, and enzymes of intermediary metabolism.
SULPHATE:
 Nutritionally essential element.
 Sulphate has anti bacterial activity and it is one of the macronutrient of cells.
 It inhibits growth of yeasts and moulds in low pH and inhibits growth of enterobacteriae
and other gram- negative bacteria in high pH.
 Sulphate important role for the anti – microbial activity.
  It is needed to start the cascade of digestive enzymes released from the pancreas. Without
proteases, lipases and amylases, food is not digested efficiently.
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SEM-Analysis of Pavalaveerachunnam
SEM-Analysis of Pavalaveerachunnam ×10,000 Magnification
SEM-Analysis of Pavalaveerachunnam - 50,000 ×Magnification
Figure No:12 SEM IMAGES OF PVC
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Interpretation:
SEM analysis of the Pavalaveerachunnamshows most of the particles present in the sample
is nano size, average particle size is 100-150 nano microns. So, very minimal quantity of
the medicine is enough to treat the disease.
Siddhars were the great scientist in ancient times. They used nano technology for
the preparation of Chunnam. Nano particles have beneficial properties that can be used to
improve drug delivery system. Target cells take up these nano particles quickly because of
their smaller size, lesser particles enhance the bio absorption and bio availability resulting
efficacy of the drug will be increased. Larger particles could not enter in to the target cell
because of their size, resulting they cleared from the body. If a drug is cleared too quickly
from the body, this could force a patient to use high dose, poor bio distribution is a problem
that can affect normal tissue through wide spread distribution but the particles from drug
delivery systems lower the volume of distribution and reduce the effect on non-target
tissue. Adjuvant and detoxification (Purification) is also important factors for drug transport.
             Nano particles are defined as particulate dispersion or solid particles with a size in
the range of 1-100nm in diameter.
They are easily
 Absorbable
 Biodegradable
 Biocompatible
 Non-antigenic in nature
 Selective/Targeted/Controlled delivery of drugs to specific site of action in the body
even across the blood brain barrier
 Use to extend time window of bioavailability and to protect drug from enzymatic
and chemical decomposition
 Result in reduced peripheral side effect of drugs
The nanoparticles present in the drug results in a better bioavailability and facilitates
absorption.
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ICP – OES (INDUCTIVELY COUPLED PLASMA OPTICAL
EMISSION SPECTROSCOPY)
PavalaveeraChunnam(wt:0.31031g)
The drug Pavalaveera chunnam sample was analysed  by the ICP-OES to
detect the trace elements and there elements quantitatively.
Table No:8  ICP – OES Result of  Pavalaveera Chunnam
S.NO Elements Wavelength Concentration
  
1. As 188.979 BDL 
2. Ca 315.807 234.150mg/L 
3. Cd 228.802 BDL 
4. Cu 327.393 BDL 
5. Fe 238.204 12.380mg/L 
6. Hg 253.652 3.574mg/L 
7. K 766.491 50.821mg/L 
8. Mg 285.213 02.020mg/L 
9. Na 589.592 02.110mg/L 
10. Ni 231.604 BDL 
11. Pb 220.353 01.254mg/L 
12. P 213.617 58.541mg/L 
13. Si 251.611 01.789mg/L 
14. S 180.731 10.514mg/L 
15. Zn 213.856 01.245mg/L 
 
BDL: Below Detectable Limit
1%  =10000 ppm,-
1ppm= 1/1000000 or 1ppm=0.0001%
The  toxic metals and the permissible limits
Heavy metals WHO&FDA limits
Arsenic( As) 10ppm
Me rcury (Hg) 1ppm
Lead(Pb) 10ppm
Cadmium(Cd) 0.3ppm
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ICP – MS (INDUCTIVELY COUPLED PLASMA OPTICAL MASS
SPECTROSCOPY)
PavalaveeraChunnam (wt:0.31031g)
The drug Pavalaveera chunnam sample was analysed  by the ICP-MS to detect
the trace elements and there elements quantitatively .
Table No:9  ICP – MS Result of  PavalaveeraChunnam
Element Element Element Actual Elemental Actual
cone in cone in cone in sample Elemental cone
Blank Sample (sample - blank) in sample
(pph) (pph) (pph) (ppm)
V 0.0040 4.2870 4.2830 0.0043
Hg 0.0040 3.4700 3.4660 0.0035
Cr 0.0479 43.1500 43.1021 0.0431
Co 0.0122 0.9758 0.9636 0.0010
Ni 0.1446 8.0640 7.9194 0.0079
Cu 0.1583 13.7330 13.5747 0.0136
As 0.0326 20.2190 20.1864 0.0202
Mo 0.0108 0.7833 0.7725 0.0008
Ru 0.0040 0.0028 -0.0012 0.0000
Rh 0.0010 0.0256 0.0246 0.0000
Pd 0.0071 0.6990 0.6918 0.0007
Cd 0.0110 0.0312 0.0202 0.0000
Os 0.0032 0.0032 0.0000 0.0000
Ir 0.0176 0.0000 -0.0176 0.0000
Pt 0.0445 0.0000 -0.0445 0.0000
Au 0.3437 25.8080 25.4643 0.0255
Pb 0.1358 1.4800 1.3442 0.0013
BDL: Below Detectable Limit
1%  =10000 ppm,-
1ppm= 1/1000000 or 1ppm=0.0001%
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The  toxic metals and the permissible limits
Heavy metals WHO&FDA limits
Arsenic( As) 10ppm
Me rcury (Hg) 1ppm
Lead(Pb) 10ppm
Cadmium(Cd) 0.3ppm
Interpretation:
The result indicate that the formulation is extremely safe as it contains heavy metals
within specified limits.
ICP-OES,ICP-MS  reveals high concentration of Sodium in pavalaveera chunnam
(589.592 mg/L). It also has physiologically important minerals like Calcium, Phosphorus
and Potassium. In pavalaveera chunnam, the heavy metals like Arsenic, Mercury, Lead,
Cadmium and trace element like Nikkal were below detectable level. This reveals the
safety of the drug and it has free from toxic substances and has no side effects. .
Sodium:
D Sodium regulates the acid-base balance of the body fluids.
D Sodium is required for the maintenance of osmotic pressure of the body fluids.
D Sodium is involved in the intestinal absorption of glucose and amino acids.
D It is necessary for the normal muscle irritability and permeability of cells.
D Sodium maintains extracellular osmotic pressure.
Potassium:
D Potassium is required for the regulation of acid-base balance and water balance of
the body fluids.
D Potassium maintains intracellular osmotic pressure.
Calcium:
D Calcium ions are necessary for the maintenance and regulation of acid-base balance
and water balance in the body.
D Calcium influences the membrane structure and transport of water and several ions
across it.
Phosphorus:
D Phosphorus plays an important role for the formation and utilization of high-energy
production
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D Phosphorus involves the function of repair of body cells  specially hepto cells and
tissues.
D Phosphate buffer system is important for the maintenance of pH in the blood(7.4)as
well as the cells.
FTIR: (FOURIER TRANSFORM INFRA-RED SPECTROSCOPY)
Fourier Transform Infra-Red Spectroscopy (FTIR) analysis results in absorption
spectra provide information about the functional group and molecular structure of a material.
In FTIR the wavenumbers between 4000cml - 600 cral is known as functional group area.
<600cml wavenumbers is known as fingerprint area. The corresponding absorption
frequency by FTIR shows the presence of alcohol, phenol, Beneze, 1°, 2°amines, amides,
alkanes, 1° amines, aromatics, aliphatic amines and alkyl halides.
Figure No:13  FTIR IMAGE OF PAVALAVEERA CHUNNAM
FTIR is a very useful tool in the recognition of the functional groups of bio molecules,
thus aiding in their structural elucidation, so confirming the presence of active molecules
responsible for the therapeutic activity of Siddha drugs.
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FUNCTIONAL GROUPS PRESETS IN Pavalaveerachunnam
Table no: 11 FTIR Spectrum-functional groups
Frequency (cm) Bond Functional groups
545.95 C – X Chloro alkanes
675.80 C – H Vinyl - Trans - disubstituted alkanes
712.28 C – H Aromatic - mono substituted benzene,
potassium persulfate,copper
1418.84 S = O sulfate
1799.10 C - O carboxylic acid - acyl halides
2512.09 N - H Ammonium ions
2873.37 N - H Ammonium ions
2924.10 N - H Ammonium ions
3434.31 - N - H Primary amines
3695.49 O - H. Alcohols,Phenols
Benzene:
 Benzene acts as a diuretic
 Benzene is natural consitutent of crude oil. Benzene is colourless,flammable
liquid with sweet odor.
 It is used as a starting material in making other chemicals,including
plastics,lubricants rubbers,dyes,detergents,drugs and pesticides.
 Toluence is often used as a substance for benzene.Toluence is also
processed into benzene.
Salts:
 Salts are very soluble in water.
 Sulfates are salts of sulfuric acid.
 Sulfate reducing bacteria,some anaerobic microorganisms.
Alkyline Group:
 In a unusual process,ammonium ions from an amalgam.Such species are
prepared by the electrolysis of an ammonium solution using a mercury
cathode.
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 Nice powder,white colour,Tasteless and no-significant smell indicates the
complete calcination process.
 Soluable in acids shows easily absoption in stomach.
Phenolic groups
 It acts as neuro transmitters
 This group of substance has antimicrobial,antiseptic and antioxidant
activities
Alkanes groups
 Alkane have little biological activity
 It is predominate in plants.They protect against bacteria and fungi.
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ACUTE TOXICITY STUDY
Acute toxicity studies were performed according to organization for economic
cooperation and development (OECD) guidelines 423 (Ecobichon and Zelt, 1979). Male
rats were selected by random sampling technique employed in this study. The animals
were fasted for 4 hours with free access to water only. The different doses of the extract
were administered orally morbitity and mortality if any was observed for 3 days. If mortality
was observed in two out of three animals, then the dose administrated was considered as
toxic dose. If the mortality was observed in only one animal out of three animals then the
same dose was repeated again to confirm the toxic effect. If no mortality was observed
then selected doses of the extract were employed for further toxicity studies.
In the present study, even 2000 mg/kg dose of Pavalaveera chunnam did not
produce any mortality and morbidity. The results of different parameters observed during
acute toxicity study are tabulated in table.12
Therefore the biological evaluation was carried out at a very conventionally safer
range of 200 and 400mg/kg doses
Table No.:12 Effect of Pavalaveera chunnam on Acute toxicity
indicates presence, -: indicates absence Sub chronic Toxicity Studies
Study Parameters Observation
1.Skin, 2.Fur, 3.Eyes, 4.Grooming, 5.Apathy, 6.Ataxia, 7.Circling, 8.Compulsive,
9.Locomotor Activity, 10.Alertness, 11.Depression, 12.Paralisis, 13.Touch response,
14.Diarrhoea, 15.Salivation, 16.Lacrimation, 17.Piloerection, 18.Convulsion, 19.Tremor,
20.Grip strength, 21.Righting reflex, 22.Corrneal Reflex, 23. Sleep, 24.Coma
In the present study showed even 2000mg/kg dose of VP did not produce any
mortality and morbidity. The results of different parameters observed during acute toxicity
study are tabulated in table No:12
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Therefore the biological evaluation was carried out at a very conventionally safer
range of l00mg, 200mg, 400mg/kg doses
The acute oral toxicity potentials of Pavalaveera Chunnnam in female Wistar
albino rats were studied effectively.
The acute toxicity result shows the test drug VP does not produce any toxic signs
and mortality up to its maximum dose level of 2000 mg/animal body weight in wister
albino rats.
Morphological characters like changes in skin, eyes, fur and nose appeared normal.
It showed changes in touch response and decreased motor activity. The behavioural
changes are normal.
According to OECD guidelines, for acute oral toxicity LDso dose upto 2000mg/
kg of the drug the test drug Pavalaveera Chunnnam is a safe herbo mineral drug and
can be used for long time administration.
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Group 
No. 
Drug 
Treatment 
Dose 
(mg/kg) 
p.o 
Food intake (g) 
   1st day 7th day 14th day 21st day 28th day 
1. Control 
(Normal 
saline) 
10ml/kg 42.53+1.30 44.78+2.10 46.56+2.30 47.78+2.38 48+1.18 
2. Drug 200 43.26+1.29 44.76+2.31 46.78+2.10 48.71+2.34 48.75+1.34 
3. Drug 400 44.54+1.38 45.23+1.45 46.89+1.98 49.10+1.32 49.87+1.68 
 
Group I Control
Group II Low dose of PVC (200mg /kg)
Group III Medium dose of PVC (400mg/kg)
Effect of Body Weight during sub-Chronic toxicity study of Pavalaveera
Chunnam
SUB ACUTE TOXICITY STUDY
Average Feed intake during sub-acute toxicity study of Pavalaveera chunnam
The average feed consumption was analyzed in group II and III animals in days
(1,7, 14,21 and 28) and compared with the group I control animals. The results are presented
in Table 11. and in the accompanying figure. The average food consumption increased
significantly in all the groups from day 1 to 29 day. The values are expressed in figure
TableNo:13 Average Feed intake during sub-acute toxicity study of PVC
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The body weight of the different treatment groups were also estimated on the days
(1,7,14,21 and 28) to assess the toxicity of Pavalaveera chunnam. The different treatment
group animals shows significant increase in body weight starting from day 1 to day 29
was observed, (figure )
Table No 13:Average Body weight during sub-acute toxicity study of PVC
Group 
No. 
Drug 
Treatment 
Dose 
(mg/kg)p.o 
Body weight (g) 
   1st day 7th day 14th day 21st day 28th day 
1. Control 
(Normal 
saline) 
10ml/kg 112+1.60 113+ 1.50 120+1.3 126+1.7 128+1.6 
2. Drug 200 113+1.70 114+1.20 121+1.70 120+1.90 122+1.50 
3. Drug 400 114+1.60 114+1.60 120+1.90 123+1.70 124+1.70 
 
Group I Control
Group II Low dose of PVC (200mg /kg)
Group III Medium dose of PVC (400mg/kg)
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SUB CHRONIC TOXICITY STUDY
Effect of organ weight during sub-acute toxicity study of Pavalaveera chunnam
The rate of size of organ per 100 grams of body weight are presented in the table
Administration of Pavalaveera chunnam different doses did not alter significantly the
organ weights in group II and III. A mild increase in the weight of lung and kidneys was
observed in Group III animals which were treated with 400mg / kg of Pavalaveera
chunnam
Table No14:Average organ weight during sub-acute toxicity study of PVC
Group 
No 
Drug 
Treatment 
Dose 
(mg/kg 
p.o) 
Brian Heart Kidney Liver Lungs 
1. Control 
(Nornal 
saline) 
10ml/kg 1.48 + 0.21 0.42=0.03 1.18 + 0.08 3.32 + 0.42 1.27 + 0.08 
2 Drug 200 1.52 + 0.07 0.43=0.05 1.16 +0.04 3.41  +0.53 1.28  +0.07 
3 Drug 400 1.53 + 0.09 0.51=0.06 1.19+ 0.07 3.52  +0.36 1.27+ 0.10 
 
Group I Control
Group II Low dose of PVC (200mg /kg)
Group III Medium dose of PVC (400mg/kg)
PRECLINICAL STUDY OF PAVALAVEERA CHUNNAM 131
Effect of Pavalaveera chunnam on Hematological parameters during sub-acute
toxicity
The hematological parameters (RBC, WBC, Platelets and Hb) were estimated in
the different groups treated with Pavalaveera chunnam and were compared with the control
animals (Group I). The WBCs increased significantly in Group III animals when compared
with Group I. The Hb showed a significant increase in group III animals. Interestingly
RBC count was significantly increased in Group III animals. The values are tabulated in
Table15
Table No 15:Average Hematological parameters during sub-acute toxicity study of
PVC
Group 
No. 
Drug 
Treatment 
Dose 
(mg/kg 
p.o) 
Haemoglobin 
gm % 
WBC 
10/cu.mm 
RBC 
10/cu.mm 
ESR 
mm/1hr 
Platelet 
(Lakhs/m) 
1. 
Control 
(Normal 
saline) 
10ml/kg 14.2 + 0.60 8.38 + 0.50 4.58 + 0.70 3.71+ 0.50 5.41 + 0.80 
2. Drug 200 13.42+0.50 7.47+0.80 4.48+0.90 3.51+ 0.03 4.70+ 0.70 
3. Drug 400 14.43+ 0.30 8.54+0.70 5.41+ 0.80 4.20+ 0.20 5.43+ 0.50 
 
Group I Control
Group II Low dose of PVC (200mg /kg)
Group III Medium dose of PVC (400mg/kg)
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Effect of Pavalaveera chunnam on Renal parameters in experimental rats.
The effect of Pavalaveera chunnam administration in kidney function was also
analyzed by estimating the levels of Glucose, Urea, creatinine and Protein the results are
presented in table Administration of Pavala veera  chunnam did not alter the kidney
function significantly. The values are shown in Table 16.
Table No 16:Average Renal parameters  during sub-acute toxicity study of PVC
Group No. Drug Treatment 
Dose 
(mg/kg) 
p.o 
Glucose 
(mg/dL.) 
Urea 
(mg/dL.) 
Creatine 
(mg/dL.) 
Total 
Protein 
(g/dL.) 
1. 
Control 
(Normal 
Saline) 
10ml/kg 103.4+1.34 43.21+1.23 0.87+ 0.78 8.31+ 0.65 
2. Drug 200  105.6+1.65 42.42+1.61 0.86+0.84 8.01+ 0.31 
3. Drug 400 104.3+1.43 42.21+1.34 0.80+ 0.84 8.90+ 0.67 
 
Group I Control
Group II Low dose of PVC (200mg /kg)
Group III Medium dose of PVC (400mg/kg)
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Effect of Pavalaveera chunnam on Liver parameters in experimental rats.
The effect of Pavalaveera chunnam in the liver function was analyzed by estimating
the levels of key enzymes namely AST, ALT, ALP and also the Bilirubin. The results are
presented in table. The administration of Pavalaveera chunnam did alter the liver
function.The total bilirubin levels didn’t show any significant increase in all the groups
when compared to the group I animals.
Table No : 17 Average Liver parameters during sub-acute toxicity study of PVC
Group No. Drug Treatment 
Dose 
(mg/kg 
p.o) 
Indirect 
Billirubin 
(mg/dL.) 
AST 
(Units/L) 
ALT 
(Units/L) 
ALP 
(Units/L) 
1. 
Control 
(Normal 
Saline) 
100ml/Kg 0.12+0.01 44.34+ 1.31 84.43+ 2.32 141.21+ 1.23 
2 .Drug 200 0.13+ 0.02 46.65+ 2.34 84.65+ 2.12 140.64 + 1.72 
3. Drug 400 0.12+ 0.02 45.34+2.14 82.54+ 2.43 135.54+ 1.45 
 
Group I Control
Group II Low dose of PVC (200mg /kg)
Group III Medium dose of PVC (400mg/kg)
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Effects of Pavalaveerachurnam on biochemical parameters of sub-acute toxicity studies
in albino rats.
The effect of Pavalaveera chunnam in the biochemical parameters was analyzed
by estimating the levels of key enzymes namely Cholesterol and Triglycerides . The results
are presented in table. The administration of Pavalaveera chunnam did alter the Cholesterol
level.
Table No:18 Average biochemical parameters during sub-acute toxicity study of
PVC
Group No. Drug Treatment Dose (mg/kg) 
Cholestrol 
(mg/dl) 
Triglycerides 
(mg/dLL 
1. Control(saline) 10 ml/kg 42.45+ 2.32 23.43+ 2.14 
2. Drug 200 42.75+ 1.78 23.74+ 1.97 
3. Drug 400 44.12+ 1.34 23.56+ 1.4 
 
Group I Control
Group II Low dose of PVC (200mg /kg)
Group III Medium dose of PVC (400mg/kg)
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Effects of Pavalaveerachurnam on biochemical parameters of sub acute toxicity studies
in albino rats.
The effect of Pavalaveera chunnam in the biochemical parameters was analyzed
by estimating the levels of key enzymes namely Albumin, Globulin, Total Bilirubin and
Direct Bilirubin . The results are presented in table. The administration of Pavalaveera
chunnam did alter the Albumin, Globulin, Total Bilirubin and Direct Bilirubin level.
Table No:19  Effect of Pavalaveera chunnam on biochemical parameter of sub-acute
toxicity studies in albino rats.
Group No. Drug Treatment 
Dose 
(mg/kg 
p.o) 
Albumin 
(g/dL) 
Globulin 
(g/dL.) 
Total 
Billirubin 
(mg/dL) 
Direct 
Billirubin 
(mg/dL) 
1. 
Control 
(Normal 
Saline) 
10ml/kg 4.32+ 1.06 4.71+ 1.05 0.23+ 0.01 0.11+ 0.01 
2. Drug 200 4.54+ 0.20 4.87+ 0.87 0.24+ 0.02 0.10+ 0.01 
3. Drug 400 5.20+ 0.78 4.91+0.92 0.25+ 0.01 0.11+ 0.01 
 
Group I Control
Group II Low dose of PVC (200mg /kg)
Group III Medium dose of PVC (400mg/kg)
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Table No 15: Effect of PVC on Histopathological study
DOSES ORGANS 
MICRO 
FATTY 
FIBROSIS CONGESTION 
LOW 
DOSE 
SPLEEN NRC NIL NIL 
HEART NRC NIL NIL 
LIVER NRC NIL NIL 
KIDNEY NRC NIL NIL 
HIGH 
DOSE 
SPLEEN NRC NIL NIL 
HEART NRC NIL NIL 
LIVER NRC NIL NIL 
KIDNEY NRC NIL NIL 
 
Interpretation:
Histopathology analysis of heart, liver, kidney shown in figure No 15. Gross
pathological examination of animals does not reveal any abnormalities in control and test
groups. Heart, Liver, Spleen and Kidney showed normal histopathology.
All other organs tested in this study showed normal architecture when compared
with control.
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PHARMACOLOGIGAL STUDY
HEPATOPROTECTIVE ACTIVITY OF PAVALAVEERA CHUNNAM
Hepatoprotective Activity of PavalaVeera Chunnam Paracetamol- induced Liver
damage in Rats
Table No. 20 Hepatoprotective Activity of Pavalaveera Chunnam
 Animals SGPT (Units/ml) 
SGOT 
(Units/ml) 
Alkaline 
Phosphates 
(U/L) 
Billirubin 
(Mg/dl) 
Control 141.32+3.25 75.34+2.15 73.04+1.35 15.1+0.65 1.09+0.35 
Standard 
silymarin 
(100mg/kg.p.o) 
135.23+2.12 76.40+1.50 79.10+2.31 17.03+0.21 1.20+0.22 
Paracetamal 
2g/kg p.o 135.42+2.13 130.67+2.31 138.07+3.21 77.62+2.12 2.51+0.31 
Sample 
200mg/kg. p.o 132.50+3.22 92.27+3.12 99.95+1.31 19.48+1.23 1.28+0.12 
Sample 
400mg/kg p.o 127.50+5.31 80.23+3.51 90.05+3.21 17.86+1.61 1.17+0.51 
 
Interpretation:
           Liver function test was increased significantly when compared with control group.
The animal which is treated with 400mg of test drug PVC the level of LFT was increased
significantly. It is concluded that the test drug has significant heptoprotective activity.
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HYPOLIPIDEMIC ACTIVITY
Table No. 23 Hypolipidemic activity of Pavalaveera chunnam
S.No Group Animals Trigycerid LDL (mg/dl) 
HDL 
(mg/dl) 
VLDL 
(mg/dl) 
1. 
Normal saline 
10ml/kg. p.o 
Control 
135+4.54 58.43+1.23 15.68+1.23 30.45+ 1.23 12.54+ 1.17 
2. 
Positive control 
400 
mg/kg(cholestor
al induced 
138+5.21 178.56+ 2.31 96+ 2.21 32.23+ 2.32 40.23+ 2.31 
3 
Group II + 
Atorvastain 
13mg/kg p.o 
124+3.52 61.24+ 1.30 15.29+2.31 30.12+ 1.09 12.35+ 1.19 
4. 
Group II + 
sample 
200mg/kg p.o 
128+ 2.10 81.24+ 1.20 21.65+ 2.34 38.21+ 3.43 17.36+ 1.26 
5. 
Group II + 
Sample 400mg / 
kg p.o 
130+1.27 60.06+ 2.12 17.25+ 1.24 13.25+ 2.28 13.21+ 1.42 
 
The mice fed with high cholesterol diet for 7 days exhibited significant increase in
serum TG, LDL and VLDL and decrease in HDL as compared to normal diet control
group. Treatment with Pavalaveera Chunnam (200mg,400mg/kg body weight) showed
significant decrease in elevated TG, LDL, and VLDL, with significant increase in HDL as
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compared to high cholesterol diet control. This lipid lowering effect may be due to the
inhibition of hepatic cholesterogenesis or due to the increase in excretion of fecal sterol
(Purohit and Vyas.,2006). Plant sterols are also reported to decrease cholesterol absorption
and they compete with dietary and biliary cholesterol for incorporation into mixed miscelles
in the intestinal lumen thus inhibiting their uptake (Brufau et al., 2008). Hyperlipidemia is
associated with the heart diseases, which is the leading cause of death in the world.
Interpretation:
The investigation of lipid lowering activity on Traditional medicines will be useful
strategy in the discovery of new molecules eliciting improved activity by regulating through
different mechanism of action.). Thus it is concluded that the test drug Pavalaveera
Chunnam has significant Hypolipidemic activity.
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DIURETIC ACTIVITY (Lipschitz test)]
Table No. 21 Diuretic Activity of Pavalaveera chunnam
Grou
p No Animal Drugs Amount of Urine Collected 
Total 
Volu
me 
(ml) 
Mean
s 
   
15mt
s 
(ml) 
30mt
s 
(ml) 
1hr 
(ml) 
2hr 
(ml) 
3hr 
(ml) 
4hr 
(ml)   
I 124.30+ 2.40 
Normal 
saline 
2ml/kg p.o 
 
0ml 
 
0.10 
 
1.0 
 
1.2 
 
0.14ml 
 
0.2ml 
 
2.64 
 
0.44 
II 125.25+ 3.32 
Standard 
frusemide 
5mg /kg p.o 
 
0.5ml 
 
1.5ml 
 
2ml 2.2ml 
 
2.6 ml 
 
2.7ml 
 
11.56 
 
1.91 
III 130.35+ 5.20 
Sample 
200mg/kg 
p.o 
 
0.3ml 
 
1.1ml 
1.5 
ml 1.8ml 2 ml 2.1 ml 8.8 1.46 
IV 133.26+ 3.54 
Sample 400 
mg/kg p.o 
 
0.6ml 
 
1.8 ml 
2.5 
ml 3.1 ml 3.4 ml 3.2 ml 14.6 2.43 
 
Interpretation:
Urinary excretion of the experimental animals was increased significantly when
compared with control group (2.64 ml). In group IV animals the urinary excretion shows
significant increase about 14.6ml. It is concluded that the test drug has significant Diuretic
activity.
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LITHOTRIPTIC ACTIVITY OF PAVALAVEERA CHUNNAM
Table No. 22 Lithotriptic activity of Pavalaveera chunnam
Group Urine levels of 
 Animals Creatine (g/l) Urea (g/l) Uric acid (g/l) 
Calcium 
(mEq/l) 
Normal saline 
(10ml/kg.p.o) 135+ 2.35 0.79+ 0.01 4.18+ 0.56 4.2+ 0.97 1.48+ 0.45 
Negative control 
(70mg/kg 
p.o)CPD 
148+3.12 0.26+0.02 7.78+0.98 6.03+0.12 2.76+ 0.93 
Cystone 
(500mg/kg. p.o) 145+2.56 0.73+0.03 4.45+0.02 4.23+0.12 3.65+ 0.08 
Sample 
(200mg/kg.p.o) 143+ 2.56 0.43+ 0.01 5.48+0.02 4.03+0.01 3.85+0.43 
Sample 
(400mg/kg.p.o)      
 
Group I Normal saline Control
Group II Positive control (400mg/kg.bw) Cholestrol induced diet,
Group III Group II + Atorvastatin (13mg/kg.p.o)
Group IV Group II + Sample drug 200mg/kg.P.O.,
Group V Group II + Sample drug 400mg / kg.P.O.
Interpretation:
Uurinary excretion of stone forming constituents in the experimental animals. The
calcium level was increased significantly when compared with control group (1.48mEg).
In group IV animals which is treated with 400mg of these drug (Pavalaveera chunnam)
the calcium level was increased significantly (4.85mEg). It is concluded that the dest drug
has significant Lithotriptic activity.
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ANTIMICROBIAL ACTIVITY
Table 18: Results of Antimicrobial activity of Pavalaveera chunnam
Micro organism Zone of inhibition in mm Inference 
 
 
Standard drug 
(Amaikacin) 50 
(ig/disc 
Test drug (VP) 
50fig/disc 
 
 
Klebsiella pneumonia 16 - Resistant 
Salmonella Typhi 17 - Resistant 
P. aeruginosa 16 - Resistant 
E. coli 16 - Resistant 
Staphylococcus albus 16        10 Sensitive 
Salmonella typhi 17 - Resistant 
Proteus vulgaris 15          - Resistant 
Streptococcus 
pyogenes 
15 10 Sensitive 
 
Micro organism Zone of inhibition in mm Inference 
Standard drug 
(Ketokonazole) 
50 ug/disc 
Test drug (VP) 
50u.g/disc 
Candida albicans 
16 - Resistant 
 Interpretation:
        From the above results, the test drug (PVC-50mcg) is resistant against Klebsiella
penumoniae, P.aeruginosa, E.coli, Salmonella typhi and Candida albicans sensitive
against Staphylococcus aureus, and Streptococcus pyogenus. Sensitive when compared
to the standard drug (Amikacin-50mcg) and ( Ketokonazole) which was evident from the
zone of inhibition.
As the above bacterial organisms responsible for pneumonia, bronchitis, pharyngitis,
diarrhoea, typhoid fever, headache, urinary tract infection and skin infectons.
And fungal organism Candida albicans responsible for superficial skin and mucosal
infection. Our results confirmed the traditional use of PVC has antimicrobial activity.
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Microbiological Results of Pavalaveerachunnam
Staphylococcus  albusor Staphylococcusepidermidis is a Gram­positive bacterium,
and one of over 40 species belonging to the genus Staphylococcus.It is part of the normal
human flora, typically the skin flora, and less commonly the mucosal flora. Although S.
epidermidis is not usually pathogenic, patients with compromised immune systems are at
risk of developing infection. These infections are generally hospital-acquired. S.
epidermidis is a particular concern for people with catheters or other surgical implants
because it is known to formbiofilms that grow on these devices. Being part of the normal
skin flora, S. epidermidis is a frequent contaminant of specimens sent to the diagnostic
laboratory. S. epidermidis causes biofilms to grow on plastic devices placed within the
body. This occurs most  commonly on intravenous catheters and on medical
prostheses. Infection can also occur in dialysis patients or anyone with an implanted plastic
device that may have been contaminated. It also causes endocarditis, most often in patients
with defective heart valves. In some other cases, sepsis can occur in hospital patients.
Streptococcus pyogenes is a species of bacteria. Like most other streptococci, it
is clinically important in human illness. It is an infrequent, but usually pathogenic, part of
the skin flora. It is the sole species of Lancefield group A and is often called group A
streptococcus (GAS),
S. pyogenes is the cause of many important human diseases, ranging from mild
superficial skin infections to life-threatening systemic diseases.Infections typically begin
in the throat or skin. The most striking sign is a strawberry-like rash. Examples of
mild S.pyogenes infections include pharyngitis (strep throat) and localized skin infection
(impetigo).Erysipelas and cellulitis are characterized by multiplication and lateral spread
of S. pyogenes in deep layers of the skin. S. pyogenes invasion and multiplication in
the fascia can lead to necrotizing fasciitis, a life­threatening condition requiring
surgery.Infections due to certain strains of S. pyogenes can be associated with the release
of bacterial toxins. Throat infections associated with release of certain toxins lead to scarlet
fever. Other toxigenic S. pyogenes infections may lead to streptococcal toxic shock
syndrome, which can be life-threatening.S. pyogenes can also cause disease in the form of
postinfectious “nonpyogenic” (not associated with local bacterial multiplication and pus
formation) syndromes. Theseautoimmune-mediated complications follow a small
percentage of infections and include rheumatic fever and acute
PRECLINICAL STUDY OF PAVALAVEERA CHUNNAM 144
postinfectious glomerulonephritis. Both conditions appear several weeks following the
initial streptococcal infection. Rheumatic fever is characterised by inflammation of the
joints and/or heart following an episode of streptococcal pharyngitis. Acute
glomerulonephritis, inflammation of the renal glomerulus, can follow streptococcal
pharyngitis or skin infection.
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6. SUMMARY
The siddha system of medicine many formulations are available for the management
of liver disease my selection of the drug “pavalaveerachunnam is a mineral, animal
formulation taken from The Pharmacopoeia of siddha research medicines” authored by
M. Shanmugavelu. Chunnam is the higher order dosage forms and specialized medicine
in siddha system. Siddhars were the great scientist in ancient times. They used nano
technology for the preparation of chunnam.Nano particles are easily absorbable,
Biodegradable, Biocompatible of the human body.
Review of the literatures and lateral research works reveals that (coral and pavalam)
ingredients of PVC used in treating liver diseases. In siddha system the liver disease is
called kalleralnoi. Liver disease is becoming ever more important. Deaths from liver disease
are rising across the world.
Review of literature in various categories was carried out. Siddha aspect, Geological,
zoological aspect and pharmaceutical review disclosed about the drug and the disease.
Pharmacological review was done to establish the methodologies.
Review of literature from various siddha texts and modern science for the ingredients
of the drug, which claims support as Hepato protective, Hypolipidemic, Diuretic and
Lithotriptic activities.
The ingredients of the drug was identified and authenticated by the experts of
Gunapadam, Geology department.
Since the trial drug pavalaveerachunnam was prepared according to the classical
methods. The purification process of this drug possible to eliminates their toxins and
increases its efficacy and the grinding, Pudam process of this drug helps to change the
particle size of the drug for its better bio availability.
The pavalaveerachunnam was screened for various standardization parameters as
per Siddha pharmacopoeial standards. The preclinical research out coming of the
standardization can be used for evaluating the quality, purity and efficacy of
pavalaveerachunnam
According to the thirithodam theory the pitha increased in liver diseases. In
panchabootha pasanam veeram is Appubootham. Pavalam is also a diuretic. Pitham is the
Thee bootham so the line of treatment is called Ehirurai.
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Physico-chemical analysis of Pavalaveerachunnam showed that loss on drying
(LOD) is 0 % which shows that no moisture content present in the prepared medicine.
Increased moisture content is the issue for instability of drug and lesser shelf-life of a
drug. Since, Pavalaveerachunnam has been well prepared it could get maximum stability
and better shelf-life. The total ash values of Pavalaveerachunnam were 3.9%, the value of
total ash in the formulation is comparatively low. The value of total ash indicates that the
inorganic contents of the formulation are below the limits. Acid-insoluble ash value of the
prepared formulation (0.8%) shows that a very small amount of the inorganic component
is insoluble in acid. It indicates that adulteration of raw ingredients by substances, such as
silica and husk, is very less. The test drug Pavalaveerachunnam having, lower the acid
insoluble value better will be the drug quality.43.3% of alcohol-soluble extractive value
and 14.2% of water-soluble extractive value of the formulation shows that the mineral
contents of the formulations are more soluble in alcohol than water and a lesser water
soluble extractive value (14.2%) of the formulation. Hence honey should be used as adjuvant
for this preparation. Specific pathogens like Salmonella sp., Staphylococcus aureus, E.coli
and Pseudomonas aeruginosaare Nil. Hence, the test drug is free from any microbial
contamination and it has standard quality.
Thin-layer chromatographyofpavalaveerachunnam shows under UV 254mm and
366mm. The RF value (0.93blue,0.46blue, 0.21blue, 0.14blue) indicates the presence of
various inorgonic compounds in this drug.
From the result of preliminary biochemical analysis reveals that trial drug
pavalaveerachunnam shows the presence of calcium, iron in ferric and ferrous form,
sulphate, chloride, phosphate. These essential elements are necessary for the normal
functioning of the body.
SEM analysis of the Pavalaveerachunnam shows most of the particles present in
the sample is nano size, average particle size is 100-150 nano microns. So, very minimal
quantity of the medicine is enough to treat the disease. Siddhars were the great scientist in
ancient times. They used nano technology for the preparation of Chunnam. Nano particles
have beneficial properties that can be used to improve drug delivery system.   Nano particles
are defined as particulate dispersion or solid particles with a size in the range of 1-100nm
in diameter. They are easily Absorbable, Biodegradable, Biocompatible,
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Non-antigenic in nature, Selective/Targeted/Controlled delivery of drugs to specific site
of action in the body even across the blood brain barrier, Use to extend time window of
bioavailability and to protect drug from enzymatic and chemical decomposition, Result in
reduced peripheral side effect of drugs. The nano particles present in the drug results in a
better bioavailability and facilitates absorption.
Fourier transform infrared spectroscopic studies of Pavalaveerachunnam shows
the presence of the following functional groups at different peaks, they are Chloro alkanes,
Vinyl - Trans - disubstituted alkanes, Aromatic - mono substituted benzene, potassium
persulfate, copper, sulfate, carboxylic acid - acyl halides, Ammonium ions, Primary amines,
Alcohols, Phenols.
Acute Toxicity study shows 2000 mg/kg dose of Pavalaveerachunnam did not
produce any mortality and morbidity. Therefore the biological evaluation was carried out
at a very conventionally safer range of 200 and 400mg/kg doses. In the present study
showed even 2000mg/kg dose of VP did not produce any mortality and morbidity.
Therefore the biological evaluation was carried out at a very conventionally safer
range of lOOmg, 200mg, 400mg/kg doses. The acute oral toxicity potentials of
PavalaveeraChunnnamin female Wistar albino rats were studied effectively. The acute
toxicity result shows the test drug PVC does not produce any toxic signs and mortality up
to its maximum dose level of 2000 mg/animal body weight in wister albino rats.
Morphological characters like changes in skin, eyes, fur and nose appeared normal. It
showed changes in touch response and decreased motor activity. The behaviorial changes
are normal. According to OECD guidelines, for acute oral toxicity LD so dose up to 2000mg/
kg of the drug the test drug PavalaveeraChunnnam is a safe mineral animal drug and can
be used for long time administration.
The average feed consumption was analyzed in group II and III animals in days
(1,7,14,21 and 28) and compared with the group I control animals. The average food
consumption increased significantly in all the groups from day 1 to 29 day.
 The body weight of the different treatment groups were also estimated on the days
(1,7,14,2land 28) to assess the toxicity of Pavalaveerachunnam. The different treatment
group animals shows significant increase in body weight starting from day 1 to day 29
was observed.
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Sub acute Toxicity Study shows administration of Pavalaveerachunnam in different
doses did not alter significantly the organ weights in group II and III. A mild increase in
the weight of lung and kidneys was observed in Group III animals which were treated
with 400mg / kg of Pavalaveerachunnam, which is reversible.
The hematological parameters (RBC, WBC, Platelets and Hb) were estimated in
the different groups treated with Pavalaveerachunnamand were compared with the control
animals (Group I). The WBCs increased significantly in Group III animals when compared
with Group I. The Hb showed a significant increase in group III animals. Interestingly
RBC count was significantly increased in Group III animals.
Pavalaveerachunnam administration in kidney function was also analyzed by
estimating the levels of Glucose, Urea, creatinine  and Protein the results are presented in
table. Administration of Pavalaveerachunnam didnot alter the kidney function significantly.
The administration of  Pavalaveerachunnam did alter the liver function.The total
bilirubin levels didn’t show any significant increase in all the groups when compared to
the group I animals.
The effect of Pavalaveerachunnam in the biochemical parameters was analyzed
by estimating the levels of key enzymes namely Cholesterol and Triglycerides and enzymes
namely Albumin, Globulin, Total Bilirubin and Direct Bilirubin . The administration of
Pavalaveerachunnam did alter the Albumin, Globulin, Total Bilirubin and Direct Bilirubin
level.
Histopathology analysis shows heart, liver, kidney, spleen and all other organs are
normal when compared with control.
Pharmacological analysis shows that the test drug Pavalaveerachunnam has got
good significant. Hepatoprotective, Hypolipidemic, Diuretic, Lithnotriptic activity when
compared to the standard drug. Thus it relieves the symptoms of liver disease.
From the above results, the test drug (PVC-50mcg) is resistant against
Klebsiellapenumoniae, P.aeruginosa, E.coli, Salmonella typhiand Candida albicans
sensitive against Staphylococcus aureus, and Streptococcus pyogenus. Sensitive when
compared to the standard drug (Amikacin-50mcg) and ( Ketokonazole) which was evident
from the zone of inhibition. As the above bacterial organisms responsible for pneumonia,
bronchitis, pharyngitis, diarrhoea, typhoid fever, headache, urinary tract infection and skin
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infectons. And fungal organism Candida albicansresponsible for superficial skin and
mucosal infection. Our results confirmed the traditional use of PVC has antimicrobial
activity.
Finally all the parameters and histopathological studies results revealed the drug
was safe in rats. Acute oral toxicity of PVC observed no toxicity. Acute and sub acute
toxicity study of Pavalaveerachunnam represents non toxic and safe drug in wistar albino
rats, biochemical parameters and histopathology results it can be concluded that the dose
level of PVC 200-400 mg mentioned in the Siddha Literature “The Pharmacopeia of
Siddha Research Medicine” authored by Shunmugavelu M. is the safety dose for human
consumption. So the test drug of PVC hope fully use for human trails.
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7. CONCLUSION
The trial drug PavalaveeraChunnam is a mineral, animal formulation, selected
from the text book of THE PHARMACOPEIA OF SIDDHA RESEARCH MEDICINES
authored by Shumugavelu M. Dr. (Page no.86) for Hepatoprotective, Hypolipidemic,
Diuretic, Lithotriptic activities and the results supported the study.
From the literature review, Physico-chemical analysis, Chemical analysis,
Pharmacological studies, Anti Microbiology activities, Instrumental analysis and
toxicological studies it is concluded that the test drug of PVC is safe and effective for
Liver Diseases and in safer to continue even for a long duration.
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8. FUTURE  SCOPE
The trial drug pavalaveerachunnam has Hepato protective, Hypolipidemic, Diuretic
and Lithotriptic activities in animal model which has been established in this study.
However, the mechanism of action by pavalaveerachunnam which produced its effect on
Hepato protective, Hypolipidemic, Diuretic and Lithotriptic activities in animal model
need to be evaluated in a scientific manner and also multi-center clinical trials are also
required to understand the exact molecular mechanisms of action. So it could be used
worldwide in treatment of Liver diseases.
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